Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	steroid hydroxylase activity	CYP3A7 CYP2D6 CYP3A4 CYP11B1 CYP11B2	4.74e-05	34	237	5	GO:0008395
GeneOntologyMolecularFunction	steroid 11-beta-monooxygenase activity	CYP11B1 CYP11B2	1.40e-04	2	237	2	GO:0004507
GeneOntologyMolecularFunction	corticosterone 18-monooxygenase activity	CYP11B1 CYP11B2	1.40e-04	2	237	2	GO:0047783
GeneOntologyMolecularFunction	benzodiazepine receptor activity	GABRA1 GABRA2 GABRA3	2.54e-04	11	237	3	GO:0008503
GeneOntologyBiologicalProcess	cell junction assembly	MAP1B MARK1 NFASC SIX4 EPB41L3 CSMD2 NRP1 NRXN3 CACNA1A PRICKLE1 PCLO PCDHB14 EPB41L5 NRG2 SHANK3 ROBO1 TNS1 GABRA1 EPHA3 GABRA2 GABRA3	2.17e-06	569	233	21	GO:0034329
GeneOntologyBiologicalProcess	synapse assembly	MAP1B MARK1 SIX4 CSMD2 NRXN3 CACNA1A PRICKLE1 PCLO PCDHB14 NRG2 SHANK3 ROBO1 GABRA1 GABRA2 GABRA3	2.45e-06	308	233	15	GO:0007416
GeneOntologyBiologicalProcess	cell morphogenesis	ASXL1 MAP1B CDH23 NFASC PDZD7 EPB41L3 DSCAML1 NRP1 NRXN3 KIDINS220 BRAF SEMA3B UPK3A CACNA1A HSPG2 SZT2 PRICKLE1 DVL2 DVL3 APBB2 EPB41L5 NR4A3 CERT1 SHANK3 LLGL1 TIAM1 CAPRIN2 CD44 ROBO1 PLEKHO1 FGD6 EPHA3	4.97e-06	1194	233	32	GO:0000902
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	MAP1B NFASC EPB41L3 DSCAML1 NRP1 NRXN3 KIDINS220 BRAF SEMA3B CACNA1A HSPG2 SZT2 PRICKLE1 DVL2 DVL3 APBB2 NR4A3 SHANK3 LLGL1 TIAM1 CAPRIN2 CD44 ROBO1 PLEKHO1 EPHA3	6.73e-06	819	233	25	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	MAP1B NFASC EPB41L3 DSCAML1 NRP1 NRXN3 KIDINS220 BRAF SEMA3B CACNA1A HSPG2 SZT2 PRICKLE1 DVL2 DVL3 APBB2 NR4A3 SHANK3 LLGL1 TIAM1 CAPRIN2 CD44 ROBO1 PLEKHO1 EPHA3	7.79e-06	826	233	25	GO:0048858
GeneOntologyBiologicalProcess	head development	NFASC RTN1 DSCAML1 NRP1 BPTF BRAF TAF1 PCDH18 CCDC14 CACNA1A HSPG2 AFF2 SZT2 PRICKLE1 DVL3 NR4A3 SHANK3 ARCN1 PITPNM1 SETD2 LLGL1 SYNGR3 ROBO1 KDM7A PCM1 PHLPP2	1.65e-05	919	233	26	GO:0060322
GeneOntologyBiologicalProcess	synapse organization	MAP1B MARK1 NFASC SIX4 CSMD2 NRP1 NRXN3 CACNA1A PRICKLE1 PCLO PCDHB14 APBB2 NRG2 SHANK3 TIAM1 CAPRIN2 ROBO1 GABRA1 EPHA3 GABRA2 GABRA3	3.58e-05	685	233	21	GO:0050808
GeneOntologyBiologicalProcess	neuron projection morphogenesis	MAP1B NFASC EPB41L3 DSCAML1 NRP1 NRXN3 KIDINS220 BRAF SEMA3B CACNA1A HSPG2 SZT2 PRICKLE1 DVL2 DVL3 APBB2 NR4A3 SHANK3 LLGL1 TIAM1 CAPRIN2 ROBO1 EPHA3	4.24e-05	802	233	23	GO:0048812
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	MAP1B CDH23 NFASC PDZD7 DSCAML1 NRP1 NRXN3 KIDINS220 BRAF SEMA3B CACNA1A HSPG2 SZT2 PRICKLE1 APBB2 NR4A3 SHANK3 LLGL1 TIAM1 CAPRIN2 ROBO1 EPHA3	4.32e-05	748	233	22	GO:0048667
GeneOntologyBiologicalProcess	brain development	NFASC RTN1 DSCAML1 NRP1 BPTF TAF1 PCDH18 CCDC14 CACNA1A HSPG2 AFF2 SZT2 DVL3 NR4A3 SHANK3 ARCN1 PITPNM1 SETD2 LLGL1 SYNGR3 ROBO1 KDM7A PCM1 PHLPP2	4.34e-05	859	233	24	GO:0007420
GeneOntologyBiologicalProcess	neuron development	PDE6C MAP1B MARK1 CDH23 NFASC PDZD7 PCDH12 EPB41L3 DSCAML1 NRP1 NRXN3 EFEMP1 KIDINS220 ALMS1 BRAF SEMA3B MINAR1 CACNA1A HSPG2 SZT2 PRICKLE1 DVL2 DVL3 APBB2 NR4A3 SHANK3 LLGL1 TIAM1 MTOR TMEM132E CAPRIN2 CD44 ROBO1 EPHA3	4.80e-05	1463	233	34	GO:0048666
GeneOntologyBiologicalProcess	neuron projection development	MAP1B MARK1 CDH23 NFASC PDZD7 EPB41L3 DSCAML1 NRP1 NRXN3 EFEMP1 KIDINS220 ALMS1 BRAF SEMA3B MINAR1 CACNA1A HSPG2 SZT2 PRICKLE1 DVL2 DVL3 APBB2 NR4A3 SHANK3 LLGL1 TIAM1 MTOR CAPRIN2 CD44 ROBO1 EPHA3	5.40e-05	1285	233	31	GO:0031175
GeneOntologyBiologicalProcess	piRNA processing	TDRD9 GPAT2 TDRKH STK31	9.89e-05	22	233	4	GO:0034587
GeneOntologyBiologicalProcess	demethylation	CYP3A7 CYP2D6 CYP3A4 KDM7A	1.41e-04	24	233	4	GO:0070988
GeneOntologyBiologicalProcess	neuromuscular process controlling balance	CDH23 CAMTA1 CACNA1A NR4A3 SHANK3 JPH3	1.90e-04	74	233	6	GO:0050885
GeneOntologyBiologicalProcess	primary alcohol metabolic process	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 CYP27C1	2.03e-04	106	233	7	GO:0034308
GeneOntologyCellularComponent	dendrite	MAP1B MARK1 CYP11B1 CYP11B2 NFASC RTN1 BPTF CNR2 CACNA1A PCLO SHANK3 TIAM1 MTOR ROBO1 HRH4 CTNND1 NCF1C NCF1B HCFC1 GABRA1 EPHA3 GABRA2 GABRA3	1.24e-04	858	237	23	GO:0030425
GeneOntologyCellularComponent	dendritic tree	MAP1B MARK1 CYP11B1 CYP11B2 NFASC RTN1 BPTF CNR2 CACNA1A PCLO SHANK3 TIAM1 MTOR ROBO1 HRH4 CTNND1 NCF1C NCF1B HCFC1 GABRA1 EPHA3 GABRA2 GABRA3	1.28e-04	860	237	23	GO:0097447
GeneOntologyCellularComponent	leading edge membrane	EPB41L3 EPB41L5 TIAM1 CD44 ROBO1 ARHGAP45 PLEKHO1 GABRA1 GABRA2 GABRA3	1.49e-04	210	237	10	GO:0031256
GeneOntologyCellularComponent	somatodendritic compartment	PDE1A MAP1B MARK1 CYP11B1 CYP11B2 NFASC RTN1 NRP1 BPTF BRS3 CNR2 CACNA1A PCLO SHANK3 TIAM1 MTOR ROBO1 HRH4 CTNND1 MAPK10 SLC24A1 NCF1C NCF1B HCFC1 GABRA1 EPHA3 GABRA2 GABRA3	3.44e-04	1228	237	28	GO:0036477
GeneOntologyCellularComponent	phagophore	ATG2A ATG2B	3.81e-04	3	237	2	GO:0061908
GeneOntologyCellularComponent	cell projection membrane	EPB41L3 MUC17 SLC5A6 EPB41L5 SHANK3 TIAM1 CD44 ROBO1 ARHGAP45 PLEKHO1 GABRA1 GABRA2 PHLPP2 GABRA3	4.31e-04	431	237	14	GO:0031253
GeneOntologyCellularComponent	cell leading edge	EPB41L3 PLEKHG5 NRBP1 APBB2 EPB41L5 TIAM1 CD44 ROBO1 CTNND1 ARHGAP45 PLEKHO1 FGD6 GABRA1 GABRA2 GABRA3	6.20e-04	500	237	15	GO:0031252
GeneOntologyCellularComponent	PR-DUB complex	ASXL1 ASXL2	7.57e-04	4	237	2	GO:0035517
MousePheno	increased circulating renin level	CYP11B1 CYP11B2 SLC12A1 NCF1C NCF1B	1.12e-05	23	187	5	MP:0003352
MousePheno	increased urine osmolality	CYP11B1 CYP11B2 SLC12A1 AKAP11	2.80e-05	14	187	4	MP:0008055
MousePheno	abnormal circulating renin level	CYP11B1 CYP11B2 SLC12A1 NCF1C NCF1B	3.72e-05	29	187	5	MP:0003349
Domain	Cyt_P450_CS	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 CYP27C1	3.95e-06	53	232	7	IPR017972
Domain	SEA	IMPG1 MUC17 HSPG2 MUC16 MUC12	6.28e-06	22	232	5	PF01390
Domain	CYTOCHROME_P450	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 CYP27C1	6.50e-06	57	232	7	PS00086
Domain	p450	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 CYP27C1	7.31e-06	58	232	7	PF00067
Domain	SEA	IMPG1 MUC17 HSPG2 MUC16 MUC12	7.94e-06	23	232	5	PS50024
Domain	SEA_dom	IMPG1 MUC17 HSPG2 MUC16 MUC12	7.94e-06	23	232	5	IPR000082
Domain	Cyt_P450	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 CYP27C1	9.20e-06	60	232	7	IPR001128
Domain	SEA	IMPG1 MUC17 HSPG2 MUC16	2.11e-05	14	232	4	SM00200
Domain	GABAAa_rcpt	GABRA1 GABRA2 GABRA3	3.68e-05	6	232	3	IPR001390
Domain	-	CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 CYP27C1	8.13e-05	58	232	6	1.10.630.10
Domain	-	PDE1A PDE3A PDE6C TBC1D10B	1.42e-04	22	232	4	1.10.1300.10
Domain	DUF3827	KIAA1549L KIAA1549	1.54e-04	2	232	2	PF12877
Domain	Cyt_P450_mitochondrial	CYP11B1 CYP11B2	1.54e-04	2	232	2	IPR002399
Domain	ATG2	ATG2A ATG2B	1.54e-04	2	232	2	IPR026849
Domain	DUF3827	KIAA1549L KIAA1549	1.54e-04	2	232	2	IPR024606
Domain	ATG2_CAD	ATG2A ATG2B	1.54e-04	2	232	2	PF13329
Domain	ATG2_CAD_motif	ATG2A ATG2B	1.54e-04	2	232	2	IPR026885
Domain	PDEase_catalytic_dom	PDE1A PDE3A PDE6C TBC1D10B	1.71e-04	23	232	4	IPR002073
Domain	SSF	SLC5A6 SLC5A12 SLC5A10	3.83e-04	12	232	3	PF00474
Domain	NA_SOLUT_SYMP_2	SLC5A6 SLC5A12 SLC5A10	3.83e-04	12	232	3	PS00457
Domain	Na/solute_symporter	SLC5A6 SLC5A12 SLC5A10	3.83e-04	12	232	3	IPR001734
Domain	NA_SOLUT_SYMP_3	SLC5A6 SLC5A12 SLC5A10	3.83e-04	12	232	3	PS50283
Domain	HARE-HTH	ASXL1 ASXL2	4.57e-04	3	232	2	PF05066
Domain	ASXH	ASXL1 ASXL2	4.57e-04	3	232	2	PF13919
Domain	PHD_3	ASXL1 ASXL2	4.57e-04	3	232	2	PF13922
Domain	ASX-like_PHD	ASXL1 ASXL2	4.57e-04	3	232	2	IPR026905
Domain	HDAC4_Gln	HDAC9 HDAC4	4.57e-04	3	232	2	PF12203
Domain	ASXH	ASXL1 ASXL2	4.57e-04	3	232	2	IPR028020
Domain	Dishevelled_C-dom	DVL2 DVL3	4.57e-04	3	232	2	IPR024580
Domain	Hist_deacetylase_Gln_rich_N	HDAC9 HDAC4	4.57e-04	3	232	2	IPR024643
Domain	Dsh_C	DVL2 DVL3	4.57e-04	3	232	2	PF12316
Domain	ASX/ASX-like	ASXL1 ASXL2	4.57e-04	3	232	2	IPR024811
Domain	HB1/Asxl_HTH	ASXL1 ASXL2	4.57e-04	3	232	2	IPR007759
Domain	TUDOR	TDRD9 TDRKH STK31	6.22e-04	14	232	3	PF00567
Domain	Ig_I-set	SIGLEC8 NFASC DSCAML1 IGSF10 CD101 HSPG2 FLT4 NRG2 ROBO1	6.33e-04	190	232	9	IPR013098
Domain	I-set	SIGLEC8 NFASC DSCAML1 IGSF10 CD101 HSPG2 FLT4 NRG2 ROBO1	6.33e-04	190	232	9	PF07679
Domain	-	IMPG1 MUC17 MUC16	7.71e-04	15	232	3	3.30.70.960
Domain	Dishevelled	DVL2 DVL3	9.07e-04	4	232	2	PF02377
Domain	Dsh/Dvl-rel	DVL2 DVL3	9.07e-04	4	232	2	IPR015506
Domain	Dishevelled_fam	DVL2 DVL3	9.07e-04	4	232	2	IPR008339
Domain	Histone_deAcase_II_euk	HDAC9 HDAC4	9.07e-04	4	232	2	IPR017320
Domain	Dishevelled_protein_dom	DVL2 DVL3	9.07e-04	4	232	2	IPR003351
Domain	Autophagy-rel_C	ATG2A ATG2B	1.50e-03	5	232	2	IPR015412
Domain	ATG_C	ATG2A ATG2B	1.50e-03	5	232	2	PF09333
Domain	Cyt_P450_E_grp-II	CYP3A7 CYP3A4	1.50e-03	5	232	2	IPR002402
Domain	PP2C	PHLPP1 PHLPP2 ILKAP	1.58e-03	19	232	3	PF00481
Domain	PP2Cc	PHLPP1 PHLPP2 ILKAP	1.84e-03	20	232	3	SM00332
Domain	-	PHLPP1 PHLPP2 ILKAP	1.84e-03	20	232	3	3.60.40.10
Domain	PPM-type_phosphatase_dom	PHLPP1 PHLPP2 ILKAP	1.84e-03	20	232	3	IPR001932
Domain	PPM_2	PHLPP1 PHLPP2 ILKAP	1.84e-03	20	232	3	PS51746
Domain	PDEase_I	PDE1A PDE3A PDE6C	2.13e-03	21	232	3	PF00233
Domain	PDEASE_I	PDE1A PDE3A PDE6C	2.13e-03	21	232	3	PS00126
Domain	PDEase_CS	PDE1A PDE3A PDE6C	2.13e-03	21	232	3	IPR023174
Domain	Cyt_P450_E_CYP3A	CYP3A7 CYP3A4	2.23e-03	6	232	2	IPR008072
Domain	RBD	BRAF TIAM1	2.23e-03	6	232	2	PF02196
Domain	FAT	TRRAP MTOR	2.23e-03	6	232	2	PS51189
Domain	FATC	TRRAP MTOR	2.23e-03	6	232	2	PS51190
Domain	FAT	TRRAP MTOR	2.23e-03	6	232	2	PF02259
Domain	PIK-rel_kinase_FAT	TRRAP MTOR	2.23e-03	6	232	2	IPR003151
Domain	FATC_dom	TRRAP MTOR	2.23e-03	6	232	2	IPR003152
Domain	PIK_FAT	TRRAP MTOR	2.23e-03	6	232	2	IPR014009
Domain	FATC	TRRAP MTOR	2.23e-03	6	232	2	SM01343
Domain	Cyt_P450_E_grp-I	CYP3A7 CYP2C18 CYP2D6 CYP27C1	2.32e-03	45	232	4	IPR002401
Domain	IGv	DSCAML1 IGSF10 CD101 HSPG2 ROBO1	2.41e-03	75	232	5	SM00406
Domain	DEP	DVL2 DVL3 DEPDC1	2.45e-03	22	232	3	PF00610
Domain	DEP	DVL2 DVL3 DEPDC1	2.45e-03	22	232	3	PS50186
Domain	DEP	DVL2 DVL3 DEPDC1	2.45e-03	22	232	3	SM00049
Domain	WD_REPEATS_1	WDR81 WDR75 TECPR2 SNRNP40 RIC1 WDR44 WDR27 TEP1 LLGL1 LRBA	2.58e-03	278	232	10	PS00678
Domain	WD_REPEATS_2	WDR81 WDR75 TECPR2 SNRNP40 RIC1 WDR44 WDR27 TEP1 LLGL1 LRBA	2.65e-03	279	232	10	PS50082
Domain	WD_REPEATS_REGION	WDR81 WDR75 TECPR2 SNRNP40 RIC1 WDR44 WDR27 TEP1 LLGL1 LRBA	2.65e-03	279	232	10	PS50294
Domain	PH_dom-like	EPB41L3 PLEKHG5 PHLPP1 RASAL2 APBB2 EPB41L5 CERT1 TIAM1 LRBA TNS1 PLEKHO1 FGD6 PHLPP2	2.68e-03	426	232	13	IPR011993
Domain	DEP_dom	DVL2 DVL3 DEPDC1	2.79e-03	23	232	3	IPR000591
Domain	GABAA/Glycine_rcpt	GABRA1 GABRA2 GABRA3	2.79e-03	23	232	3	IPR006028
Domain	TUDOR	TDRD9 TDRKH STK31	2.79e-03	23	232	3	PS50304
Domain	PDZ	PDZD7 PCLO DVL2 DVL3 SHANK3 TIAM1 LMO7	2.84e-03	151	232	7	PS50106
Domain	PDZ	PDZD7 PCLO DVL2 DVL3 SHANK3 TIAM1 LMO7	2.94e-03	152	232	7	IPR001478
Domain	-	WDR81 WDR75 TECPR2 SEMA3B SNRNP40 RIC1 WDR44 WDR27 TEP1 LLGL1 LRBA	3.09e-03	333	232	11	2.130.10.10
Domain	SLC12A_fam	SLC12A6 SLC12A1	3.10e-03	7	232	2	IPR004842
Domain	RBD	BRAF TIAM1	3.10e-03	7	232	2	SM00455
Domain	DIX	DVL2 DVL3	3.10e-03	7	232	2	PF00778
Domain	RBD_dom	BRAF TIAM1	3.10e-03	7	232	2	IPR003116
Domain	RBD	BRAF TIAM1	3.10e-03	7	232	2	PS50898
Domain	DIX	DVL2 DVL3	3.10e-03	7	232	2	IPR001158
Domain	DIX	DVL2 DVL3	3.10e-03	7	232	2	PS50841
Domain	DAX	DVL2 DVL3	3.10e-03	7	232	2	SM00021
Domain	HD/PDEase_dom	PDE1A PDE3A PDE6C	3.16e-03	24	232	3	IPR003607
Domain	HDc	PDE1A PDE3A PDE6C	3.16e-03	24	232	3	SM00471
Domain	WD40/YVTN_repeat-like_dom	WDR81 WDR75 TECPR2 SEMA3B SNRNP40 RIC1 WDR44 WDR27 TEP1 LLGL1 LRBA	3.24e-03	335	232	11	IPR015943
Pathway	WP_OXIDATION_BY_CYTOCHROME_P450	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 CYP27C1	1.39e-05	62	181	7	M39653
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC17 MUC16 MUC12 MUC6	4.24e-05	16	181	4	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC17 MUC16 MUC12 MUC6	5.49e-05	17	181	4	M27412
Pathway	BIOCARTA_FLUMAZENIL_PATHWAY	GABRA1 GABRA2 GABRA3	1.65e-04	9	181	3	M22034
Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2	1.67e-04	64	181	6	M5650
Pathway	REACTOME_XENOBIOTICS	CYP3A7 CYP2C18 CYP2D6 CYP3A4	1.92e-04	23	181	4	M5372
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC16 MUC12 MUC6	1.92e-04	23	181	4	M556
Pathway	BIOCARTA_GABA_PATHWAY	GABRA1 GABRA2 GABRA3	2.34e-04	10	181	3	M477
Pathway	BIOCARTA_GABA_PATHWAY	GABRA1 GABRA2 GABRA3	2.34e-04	10	181	3	MM1401
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	STOX2 KIDINS220 ALMS1 SVIL NUFIP2 RASAL2 SYNM RBM33 DVL2 DVL3 EPB41L5 KIAA1549 MEIOC LRBA CTNND1	5.20e-10	263	239	15	34702444
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DLGAP5 NFASC ATG2A PLEKHG5 STOX2 NRXN3 TECPR2 MED13 RELCH PDPR SZT2 KIAA1549 G2E3 CLOCK TUBGCP6 LMO7 CAPRIN2 AKAP11 KDM7A L3MBTL3	9.54e-10	529	239	20	14621295
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	SYNRG RTN1 KIDINS220 ALMS1 UBR5 ARHGAP29 RASAL2 ATG2B RABEP1 ROBO1 AKAP11 CTNND1 PCM1	2.67e-09	209	239	13	36779422
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ILF2 HDAC4 DLGAP5 WDR81 ZMYM2 NFASC EPB41L3 RTN1 STOX2 ZNF394 UBR5 SVIL NUFIP2 RASAL2 CACNA1A DRG2 CALCOCO1 DVL2 SHANK3 MTOR RABEP1 SSH2 CTNND1 TNS1 PCM1	1.55e-08	963	239	25	28671696
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SYNRG CYP2C18 DLGAP5 ZMYM2 SLCO4A1 SMARCAD1 TRRAP BPTF BRAF RRP12 SVIL MED13 WDR44 YBX3 PITPNM1 TUBGCP6 TBC1D10B SETD2 LMO7 EIF3G STAG2 PCM1	2.45e-08	774	239	22	15302935
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	DLGAP5 KIDINS220 NUFIP2 PHLPP1 SYNM ATG2B DVL2 DVL3 LMO7 ROBO1 CTNND1 HCFC1 PCM1	3.01e-08	256	239	13	33397691
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SYNRG HDAC4 MAP1B EPB41L3 STOX2 ALMS1 BRAF SVIL RASAL2 DRG2 EPB41L5 ALPK1 NSMCE2 TBC1D10B TIAM1 LMO7 MTOR RABEP1 AKAP11 SSH2 CTNND1 FGD6 PCM1	3.60e-08	861	239	23	36931259
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	APH1B HDAC4 MAP1B NFASC TRRAP NRP1 BPTF KIDINS220 TECPR2 NUP210 SEMA3B CAMTA1 RIC1 ATMIN PRUNE2 SLC12A6 DTNA ABHD2 CALCOCO1 APBB2 WDR27 G2E3 NSMCE2 TEP1 CERT1 RABEP1 NAXD LRBA CTNND1 STAG2 PCM1	4.37e-08	1489	239	31	28611215
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ASXL1 NFASC DSCAML1 ALMS1 UBR5 PHLPP1 MINAR1 CAMTA1 PRUNE2 ALPK1 LMO7 AKAP11	6.05e-08	225	239	12	12168954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HDAC9 MARK1 EPB41L3 ALMS1 NUP210 MINAR1 EXOC7 PCDH18 RIC1 PRUNE2 SYNM EPB41L5 ALPK1 SHANK3 SETD2 SSH2 FGD6	6.80e-08	493	239	17	15368895
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	SIX4 RRP12 SVIL NUP210 NUFIP2 PHLPP1 CCDC14 KRT2 RELCH PDPR DTNA KIAA1549 ELP1 TBC1D10B TIAM1 PPP4R2 CD44 ROBO1 SSH2 CTNND1 L3MBTL3 TNS1 PHLPP2 ILKAP FTSJ3	8.04e-08	1049	239	25	27880917
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	SLCO4A1 KIDINS220 BRAF FAM83F PCDH18 RASAL2 RELCH DTNA EPB41L5 KIAA1549 TBC1D10B LLGL1 MTOR CD44 LRBA CTNND1 FGD6 EPHA3	1.01e-07	569	239	18	30639242
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ILF2 MAP1B EPB41L3 KIDINS220 NUFIP2 ARHGAP29 RASAL2 DTNA ATG2B DVL2 EPB41L5 ARCN1 TBC1D10B LLGL1 ROBO1 EIF3G LRBA CTNND1 HCFC1 EPHA3	1.20e-07	708	239	20	39231216
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	MAP1B EPB41L3 RTN1 NUFIP2 CACNA1A PCLO NRG2 PITPNM1 CTNND1 MAPK10 PCM1 GABRA1 JPH3 GABRA3	1.53e-07	347	239	14	17114649
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SYNRG MAP1B TRRAP BPTF ALMS1 NUFIP2 TAF1 WDR44 ATG2B ARCN1 SETD2 LMO7 RABEP1 LRBA CTNND1 HCFC1 PCM1	3.10e-07	549	239	17	38280479
Pubmed	Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons.	GABRA1 GABRA2 GABRA3	3.20e-07	3	239	3	16835366
Pubmed	Specific GABAA circuits for visual cortical plasticity.	GABRA1 GABRA2 GABRA3	3.20e-07	3	239	3	15017002
Pubmed	Analysis of the presence and abundance of GABAA receptors containing two different types of alpha subunits in murine brain using point-mutated alpha subunits.	GABRA1 GABRA2 GABRA3	3.20e-07	3	239	3	15304513
Pubmed	The alpha 1, alpha 2, and alpha 3 subunits of GABAA receptors: comparison in seizure-prone and -resistant mice and during development.	GABRA1 GABRA2 GABRA3	3.20e-07	3	239	3	1356407
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	PDE3A DLGAP5 ZMYM2 EPB41L3 ZXDA BRAF RRP12 NUFIP2 EXOC7 WDR44 NRBP1 LMO7 GMEB1 HCFC1 PCM1 FTSJ3	4.90e-07	503	239	16	16964243
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	WDR81 ATG2A CHM RTN1 KIDINS220 COG6 MIGA1 RIC1 RASAL2 SLC12A6 TDRKH ATG2B APBB2 AKAP11 LRBA CTNND1	5.02e-07	504	239	16	34432599
Pubmed	Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 CYP27C1	5.50e-07	70	239	7	15128046
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SYNRG MAP1B DLGAP5 ZMYM2 EPB41L3 RTN1 ALMS1 RRP12 NUFIP2 WDR44 ATG2B DVL2 ARCN1 SETD2 RABEP1 EIF3G LRBA CTNND1 HCFC1 PCM1 ILKAP FTSJ3	6.12e-07	934	239	22	33916271
Pubmed	CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.	CYP3A7 CYP2C18 CYP2D6 CYP3A4	1.03e-06	12	239	4	15319333
Pubmed	The α1, α2, α3, and γ2 subunits of GABAA receptors show characteristic spatial and temporal expression patterns in rhombencephalic structures during normal human brain development.	GABRA1 GABRA2 GABRA3	1.28e-06	4	239	3	26518133
Pubmed	GABA(A) receptor downregulation in brains of subjects with autism.	GABRA1 GABRA2 GABRA3	1.28e-06	4	239	3	18821008
Pubmed	Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype.	GABRA1 GABRA2 GABRA3	1.28e-06	4	239	3	25865415
Pubmed	Molecular and functional diversity of GABA-A receptors in the enteric nervous system of the mouse colon.	GABRA1 GABRA2 GABRA3	1.28e-06	4	239	3	25080596
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	SYNRG MAP1B MARK1 HMGCL EPB41L3 RTN1 NUFIP2 NAV3 CACNA1A RELCH DTNA PCLO ATG2B DVL2 DVL3 SHANK3 ARCN1 PITPNM1 RABEP1 CTNND1 PCM1 GABRA1 JPH3 GABRA2	1.32e-06	1139	239	24	36417873
Pubmed	A human MAP kinase interactome.	HDAC9 HDAC4 ZMYM2 EPB41L3 KIAA1549L BRAF NAV3 TAF1 WDR44 CCDC14 RBM33 MUC12 ROBO1 MAPK10 TNS1	1.63e-06	486	239	15	20936779
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	HDAC4 EPB41L3 BRAF SVIL NUFIP2 RASAL2 TIAM1 LMO7 RABEP1 CTNND1 FGD6	1.76e-06	255	239	11	15324660
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	EPB41L3 VPS52 KIDINS220 UBR5 RASAL2 KRT2 TDRKH AFF2 SYNM APBB2 EPB41L5 MUC16 ARCN1 STK33 CD44 ROBO1 LRBA CTNND1 PCM1	2.15e-06	777	239	19	35844135
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ILF2 MAP1B MARK1 NFASC EPB41L3 PLEKHG5 RTN1 KIDINS220 SVIL NUFIP2 RASAL2 CACNA1A SLC12A6 KRT2 PCLO CALCOCO1 KIAA1549 ELP1 SHANK3 ARCN1 PITPNM1 LMO7 SYNGR3 SSH2 CTNND1 TNS1 PCM1	2.27e-06	1431	239	27	37142655
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	EPB41L3 KIDINS220 SLC5A6 RASAL2 WDR44 EPB41L5 TBC1D10B LLGL1 TIAM1 CD44 ROBO1 CTNND1 EPHA3	2.46e-06	377	239	13	38117590
Pubmed	Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.	CYP3A7 CYP2C18 CYP3A4	3.17e-06	5	239	3	11093772
Pubmed	Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors.	GABRA1 GABRA2 GABRA3	3.17e-06	5	239	3	30104684
Pubmed	Intrinsically Disordered Protein TEX264 Mediates ER-phagy.	SYNRG MAP1B ATG2A KRT2 LMO7 RABEP1 AKAP11 LRBA	3.70e-06	131	239	8	31006538
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC17 MUC16 MUC12 MUC6	6.17e-06	18	239	4	18834073
Pubmed	Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.	HDAC4 DVL2 DVL3	6.31e-06	6	239	3	34139860
Pubmed	Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5.	GABRA1 GABRA2 GABRA3	6.31e-06	6	239	3	15033447
Pubmed	NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis.	CD44 NCF1C NCF1B	6.31e-06	6	239	3	20558727
Pubmed	GABAA receptor signaling in caudal periaqueductal gray regulates maternal aggression and maternal care in mice.	GABRA1 GABRA2 GABRA3	6.31e-06	6	239	3	20457185
Pubmed	Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature.	CD44 NCF1C NCF1B	6.31e-06	6	239	3	25809117
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZMYM2 EPB41L3 ALMS1 UBR5 TAF1 DRG2 ATG2B DVL2 DVL3 RABEP1 LRBA L3MBTL3 PCM1	7.49e-06	418	239	13	34709266
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ALMS1 TECPR2 DNAH9 PRUNE2 SYNM CLOCK CTNND1	7.99e-06	104	239	7	9205841
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	MARK1 KIDINS220 RASAL2 SLC12A6 DTNA APBB2 EPB41L5 TBC1D10B LLGL1 ROBO1 LRBA CTNND1 EPHA3	8.09e-06	421	239	13	36976175
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ASXL1 MAP1B ZMYM2 SMARCAD1 SIX4 TRRAP ZBTB37 BPTF UBR5 SMARCAL1 DVL2 DEPDC1 E4F1 SYNGR3 ASXL2 CTNND1 L3MBTL3 HCFC1 STAG2	8.68e-06	857	239	19	25609649
Pubmed	Identification of an FMNL2 Interactome by Quantitative Mass Spectrometry.	EPB41L3 KIDINS220 EPB41L5 TBC1D10B LLGL1 ROBO1 CTNND1	9.06e-06	106	239	7	38891874
Pubmed	Molecular genetics of the human cytochrome P450 monooxygenase superfamily.	CYP3A7 CYP2C18 CYP2D6 CYP3A4	9.66e-06	20	239	4	9890157
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	MAP1B TRRAP BPTF RRP12 NUP210 SNRNP40 SYNM SETD2 TIAM1 FTSJ3	1.01e-05	250	239	10	33536335
Pubmed	Hepatitis C virus infection protein network.	ITGAL VPS52 EFEMP1 RASAL2 SETD2	1.02e-05	42	239	5	18985028
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	HDAC9 DCHS2 ZMYM2 SMARCAD1 DSCAML1 EFEMP1 NAV3 MIGA1 TAF1 EXOC7 MED13 RASAL2 NRBP1 SYNM DVL3 APBB2 ARCN1 TIAM1 LMO7 RABEP1 ROBO1 LRBA PCM1 JPH3	1.02e-05	1285	239	24	35914814
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	ILF2 MAP1B EPB41L3 VPS52 RRP12 SVIL SNRNP40 DRG2 PCLO DVL2 DVL3 EPB41L5 HCFC1 STAG2	1.05e-05	498	239	14	36634849
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	PDE1A EPB41L3 UBR5 WDR44 ATG2B DVL2 DVL3 ARCN1 PITPNM1 CD44 ROBO1 EIF3G LRBA HCFC1 PCM1	1.06e-05	568	239	15	37774976
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SMARCAD1 EPB41L3 TRRAP BPTF VPS52 ALMS1 UBR5 RTL9 TAF1 TDRKH DVL2 KIAA1549 TEP1 TUBGCP6 TBC1D10B SETD2 EAF1 CCNB3 CAPRIN2 VPS53 PCM1 FTSJ3	1.06e-05	1116	239	22	31753913
Pubmed	Developmental changes in GABA receptor subunit composition within the gonadotrophin-releasing hormone-1 neuronal system.	GABRA1 GABRA2 GABRA3	1.10e-05	7	239	3	16101898
Pubmed	Dishevelled proteins regulate cell adhesion in mouse blastocyst and serve to monitor changes in Wnt signaling.	DVL2 DVL3 CTNND1	1.10e-05	7	239	3	17005174
Pubmed	Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia.	GABRA1 GABRA2 GABRA3	1.10e-05	7	239	3	20843900
Pubmed	Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO).	GABRA1 GABRA2 GABRA3	1.10e-05	7	239	3	35228700
Pubmed	Cloning and characterization of mouse intestinal MUC3 mucin: 3' sequence contains epidermal-growth-factor-like domains.	MUC17 NCF1C NCF1B	1.10e-05	7	239	3	9494100
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	MAP1B ZMYM2 EPB41L3 NRP1 KIDINS220 WDR75 SVIL DTNA LLGL1 CTNND1 HCFC1	1.23e-05	313	239	11	38270169
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ILF2 SMARCAD1 EPB41L3 KIDINS220 WDR75 UBR5 RRP12 NUP210 SNRNP40 RASAL2 NRBP1 PDPR DRG2 SYNM DTNA EPB41L5 KIAA1549 ELP1 TUBGCP6 LLGL1 TIAM1 ROBO1 AKAP11 CTNND1 PCM1 FTSJ3	1.35e-05	1487	239	26	33957083
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ILF2 MAP1B EPB41L3 TRRAP BPTF WDR75 UBR5 RRP12 NUP210 NUFIP2 ELP1 MTOR HCFC1 STAG2 PCM1 FTSJ3	1.36e-05	653	239	16	22586326
Pubmed	A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir.	CYP3A7 CYP2D6 CYP3A4	1.75e-05	8	239	3	20147896
Pubmed	gamma-Aminobutyric acidA receptors displaying association of gamma 3-subunits with beta 2/3 and different alpha-subunits exhibit unique pharmacological properties.	GABRA1 GABRA2 GABRA3	1.75e-05	8	239	3	8175718
Pubmed	GABA(A) receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1.	GABRA1 GABRA2 GABRA3	1.75e-05	8	239	3	11528422
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	TTC39B ASXL1 TMEM42 CYP3A4 CDH23 TRRAP ZNF394 COG6 SLC5A6 RASAL2 NRBP1 SMARCAL1 ELP1 ALPK1 IFI27 CERT1 PITPNM1 SLC16A6 MTOR CAPRIN2 KDM7A MAPK10 VPS53	1.79e-05	1242	239	23	30973865
Pubmed	Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia.	VPS52 EFEMP1 COG6 CACNA1A HSPG2 LLGL1 RABEP1	1.83e-05	118	239	7	21078624
Pubmed	Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.	MARK1 EPB41L3 KIDINS220 BRAF ATG2B EPB41L5 LLGL1 TIAM1 ROBO1 CTNND1 PLEKHO1 LRIF1 EPHA3	2.40e-05	467	239	13	30194290
Pubmed	Expression of planar cell polarity genes during development of the mouse CNS.	PRICKLE1 DVL2 DVL3	2.61e-05	9	239	3	16487141
Pubmed	The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.	ASXL1 ASXL2 HCFC1	2.61e-05	9	239	3	26416890
Pubmed	Proteomic analysis of in vivo phosphorylated synaptic proteins.	MAP1B NFASC EPB41L3 RTN1 PCLO	3.22e-05	53	239	5	15572359
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	HDAC4 EPB41L3 DSCAML1 ALMS1 RRP12 MED13 KIAA1549	3.42e-05	130	239	7	12421765
Pubmed	Tiam1 regulates the Wnt/Dvl/Rac1 signaling pathway and the differentiation of midbrain dopaminergic neurons.	DVL2 DVL3 TIAM1	3.71e-05	10	239	3	23109420
Pubmed	Inhibitory synapse dysfunction and epileptic susceptibility associated with KIF2A deletion in cortical interneurons.	GABRA1 GABRA2 GABRA3	3.71e-05	10	239	3	36733270
Pubmed	Functional modifications of acid-sensing ion channels by ligand-gated chloride channels.	GABRA1 GABRA2 GABRA3	3.71e-05	10	239	3	21789198
Pubmed	ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.	ASXL1 ASXL2 HCFC1	3.71e-05	10	239	3	32669118
Pubmed	The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.	ASXL1 ASXL2 HCFC1	3.71e-05	10	239	3	19815555
Pubmed	Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.	CYP3A7 CYP2D6 CYP3A4	3.71e-05	10	239	3	12865317
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	ALMS1 UBR5 SVIL ARHGAP29 RASAL2 CCDC14 SYNM PCM1	4.38e-05	184	239	8	32908313
Pubmed	Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7.	CYP3A7 CYP3A4	4.70e-05	2	239	2	28986474
Pubmed	GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism.	CYP11B1 CYP11B2	4.70e-05	2	239	2	35012455
Pubmed	Role of genetic variation in regulation of aldosterone biosynthesis.	CYP11B1 CYP11B2	4.70e-05	2	239	2	21164264
Pubmed	Atg2A/B deficiency switches cytoprotective autophagy to non-canonical caspase-8 activation and apoptosis.	ATG2A ATG2B	4.70e-05	2	239	2	28800131
Pubmed	Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward.	GABRA2 GABRA3	4.70e-05	2	239	2	22763624
Pubmed	Lower serum CA125 level, negative vascular invasion, and wild BRAF were strongly associated with better 2-year disease-free survival in patients with stage III colorectal cancer who received adjuvant chemotherapy.	BRAF MUC16	4.70e-05	2	239	2	29562502
Pubmed	Mammalian Atg2 proteins are essential for autophagosome formation and important for regulation of size and distribution of lipid droplets.	ATG2A ATG2B	4.70e-05	2	239	2	22219374
Pubmed	A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I.	CYP11B1 CYP11B2	4.70e-05	2	239	2	20634641
Pubmed	Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator.	CYP2D6 CYP3A4	4.70e-05	2	239	2	20007670
Pubmed	Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages.	MRC1 MUC16	4.70e-05	2	239	2	21331365
Pubmed	α2-containing GABAA receptors expressed in hippocampal region CA3 control fast network oscillations.	GABRA1 GABRA2	4.70e-05	2	239	2	23109109
Pubmed	PHLPP isoforms differentially regulate Akt isoforms and AS160 affecting neuronal insulin signaling and insulin resistance via Scribble.	PHLPP1 PHLPP2	4.70e-05	2	239	2	36376971
Pubmed	Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans.	CYP11B1 CYP11B2	4.70e-05	2	239	2	1741400
Pubmed	The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.	CYP2D6 CYP3A4	4.70e-05	2	239	2	25868121
Pubmed	Characterization of the effects of cross-linking of macrophage CD44 associated with increased phagocytosis of apoptotic PMN.	TIAM1 CD44	4.70e-05	2	239	2	22427969
Pubmed	PHLPPing through history: a decade in the life of PHLPP phosphatases.	PHLPP1 PHLPP2	4.70e-05	2	239	2	27913677
Pubmed	Activation of leukocyte beta2 integrins by conversion from bent to extended conformations.	ITGAL ITGAX	4.70e-05	2	239	2	17045822
Pubmed	Aldosterone-dependent and -independent regulation of the epithelial sodium channel (ENaC) in mouse distal nephron.	CYP11B1 CYP11B2	4.70e-05	2	239	2	22933298
Pubmed	Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjects.	CYP2D6 CYP3A4	4.70e-05	2	239	2	16633141
Pubmed	EPHA3 enhances macrophage autophagy and apoptosis by disrupting the mTOR signaling pathway in mice with endometriosis.	MTOR EPHA3	4.70e-05	2	239	2	31262977
Interaction	WWTR1 interactions	HDAC9 SYNRG MAP1B TRRAP BPTF ALMS1 WDR44 ATG2B DVL2 DVL3 CLOCK ARCN1 SETD2 LMO7 RABEP1 LRBA CTNND1 HCFC1 PCM1	5.45e-07	422	234	19	int:WWTR1
Interaction	GSK3B interactions	SYNRG HDAC4 MAP1B SREBF1 EPB41L3 RTN1 KIDINS220 ALMS1 UBR5 ARHGAP29 PHLPP1 RASAL2 NRBP1 RBM33 ATG2B DVL2 YBX3 SHANK3 ARCN1 MTOR RABEP1 ROBO1 AKAP11 CTNND1 PLEKHO1 PCM1 ILKAP	3.29e-06	868	234	27	int:GSK3B
Interaction	STX6 interactions	SYNRG VPS52 KIDINS220 COG6 RIC1 RASAL2 SLC12A6 RELCH DTNA APBB2 EPB41L5 TBC1D10B LLGL1 RABEP1 ROBO1 LRBA CTNND1 VPS53	5.41e-06	448	234	18	int:STX6
Interaction	RNF43 interactions	STOX2 KIDINS220 ALMS1 UBR5 SVIL NUFIP2 RASAL2 SYNM RBM33 DVL2 DVL3 EPB41L5 KIAA1549 YBX3 MEIOC LRBA CTNND1	1.12e-05	427	234	17	int:RNF43
Interaction	CTDSPL interactions	MAGEA8 DTNA KIAA1549 TBC1D10B TIAM1 CD44 ROBO1 CTNND1	1.18e-05	92	234	8	int:CTDSPL
Interaction	PHF21A interactions	ZMYM2 ALMS1 UBR5 SNRNP40 TAF1 DRG2 ATG2B DVL2 DVL3 CLOCK RABEP1 LRBA L3MBTL3 VPS53 PCM1	1.24e-05	343	234	15	int:PHF21A
Interaction	CASQ1 interactions	TRDN DVL2 ILKAP	1.52e-05	5	234	3	int:CASQ1
Interaction	RAB4A interactions	SYNRG SLCO4A1 ATG2A CHM NRP1 VPS52 KIDINS220 SLC12A6 RELCH ATG2B EPB41L5 KIAA1549 RABEP1 CD44 LRBA CTNND1 VPS53	2.66e-05	457	234	17	int:RAB4A
Interaction	EZR interactions	HDAC4 RTN1 KIDINS220 SVIL RASAL2 WDR44 DTNA DVL3 EPB41L5 KIAA1549 ELP1 LMO7 RABEP1 CD44 LRBA CTNND1 MAPK10 PHLPP2 FTSJ3	2.67e-05	553	234	19	int:EZR
Interaction	STX7 interactions	SYNRG SLCO4A1 EPB41L3 RTN1 NRP1 KIDINS220 RASAL2 WDR44 SLC12A6 RELCH DTNA APBB2 EPB41L5 KIAA1549 TBC1D10B LLGL1 TIAM1 ROBO1 LRBA CTNND1 VPS53	3.03e-05	659	234	21	int:STX7
Interaction	PHLPP1 interactions	DLGAP5 KIDINS220 NUFIP2 PHLPP1 SYNM ATG2B DVL2 DVL3 LMO7 ROBO1 CTNND1 HCFC1 PCM1 PHLPP2	3.74e-05	333	234	14	int:PHLPP1
Interaction	HRAS interactions	HDAC4 SLCO4A1 BRAF FAM83F ARHGAP29 RASAL2 WDR44 RELCH EPB41L5 KIAA1549 YBX3 TBC1D10B LLGL1 TIAM1 MTOR CD44 ROBO1 LRBA CTNND1 MAPK10 PLEKHO1 FGD6	4.08e-05	725	234	22	int:HRAS
Interaction	PARD3 interactions	HDAC4 KIDINS220 ARHGAP29 RASAL2 DTNA DVL2 EPB41L5 KIAA1549 LLGL1 TIAM1 LMO7 CTNND1 EPHA3	4.87e-05	298	234	13	int:PARD3
Interaction	SFN interactions	HDAC9 SYNRG HDAC4 MAP1B MARK1 STOX2 ALMS1 BRAF SVIL RASAL2 NRBP1 KRT2 EPB41L5 CERT1 TIAM1 LMO7 MTOR AKAP11 SSH2 EIF3G FGD6	6.13e-05	692	234	21	int:SFN
Interaction	ZFPL1 interactions	EPB41L3 TRDN KIDINS220 RIC1 RASAL2 DTNA EPB41L5 KIAA1549 ARCN1 TBC1D10B LLGL1 TIAM1 ROBO1 LRBA CTNND1 PLEKHO1	7.45e-05	448	234	16	int:ZFPL1
Interaction	C11orf52 interactions	MARK1 EPB41L3 KIDINS220 RASAL2 DTNA EPB41L5 KIAA1549 TBC1D10B LLGL1 TIAM1 ROBO1 CTNND1 EPHA3	7.52e-05	311	234	13	int:C11orf52
Interaction	NXF2 interactions	MAP1B STOX2 DVL2 DVL3 SETD2 MEIOC	1.07e-04	65	234	6	int:NXF2
Interaction	RAB11A interactions	SYNRG HDAC4 HMGCL CHM NRP1 KIDINS220 RRP12 EXOC7 RASAL2 WDR44 RELCH APBB2 EPB41L5 KIAA1549 LLGL1 RABEP1 CD44 ROBO1 EIF3G LRBA CTNND1 VPS53 FTSJ3	1.07e-04	830	234	23	int:RAB11A
Interaction	DUSP16 interactions	MAP1B ALMS1 COG6 CCDC14 SZT2 ATG2B TUBGCP6 MEIOC AKAP11 MAPK10 PCM1	1.08e-04	237	234	11	int:DUSP16
Interaction	CFAP184 interactions	MAP1B VPS52 ALMS1 CCDC14 ATG2B TUBGCP6 SETD2 AKAP11 PCM1	1.19e-04	162	234	9	int:CFAP184
GeneFamily	CD molecules\|Mucins	MUC17 MUC16 MUC12 MUC22 MUC6	1.08e-06	21	165	5	648
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NFASC DSCAML1 IGSF10 CD101 HSPG2 FLT4 NRG2 ROBO1	1.17e-04	161	165	8	593
GeneFamily	Cytochrome P450 family 11	CYP11B1 CYP11B2	2.47e-04	3	165	2	1007
GeneFamily	Protein phosphatases, Mg2+/Mn2+ dependent	PHLPP1 PHLPP2 ILKAP	4.62e-04	17	165	3	701
GeneFamily	Histone deacetylases, class IIA	HDAC9 HDAC4	4.91e-04	4	165	2	992
GeneFamily	Dishevelled segment polarity proteins\|PDZ domain containing	DVL2 DVL3	4.91e-04	4	165	2	505
GeneFamily	PDZ domain containing	PDZD7 PCLO DVL2 DVL3 SHANK3 TIAM1 LMO7	4.96e-04	152	165	7	1220
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG5 PHLPP1 RASAL2 CERT1 TIAM1 PLEKHO1 FGD6 PHLPP2	6.18e-04	206	165	8	682
GeneFamily	Gamma-aminobutyric acid type A receptor subunits	GABRA1 GABRA2 GABRA3	6.50e-04	19	165	3	563
GeneFamily	Phosphodiesterases	PDE1A PDE3A PDE6C	1.31e-03	24	165	3	681
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 CD44	1.69e-03	7	165	2	570
GeneFamily	Cytochrome P450 family 3	CYP3A7 CYP3A4	2.24e-03	8	165	2	1002
GeneFamily	WD repeat domain containing	WDR81 WDR75 SNRNP40 WDR44 WDR27 TEP1 LLGL1 LRBA	2.84e-03	262	165	8	362
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDR81 LRBA	2.86e-03	9	165	2	1230
GeneFamily	Tudor domain containing	TDRD9 TDRKH STK31	4.62e-03	37	165	3	780
GeneFamily	Non-clustered protocadherins	PCDH12 PCDH18	5.15e-03	12	165	2	21
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	PDE1A MAP1B MARK1 NFASC PDZD7 CSMD2 RTN1 DSCAML1 STOX2 NRXN3 KIAA1549L NAV3 CAMTA1 RASAL2 CACNA1A AFF2 RBM33 PCLO KIAA1549 CERT1 SHANK3 SYNGR3 CAPRIN2 ROBO1 SSH2 VPS53 GABRA1 JPH3 EPHA3 GABRA2	9.50e-08	1106	238	30	M39071
Coexpression	HALLMARK_MITOTIC_SPINDLE	DLGAP5 ALMS1 ARHGAP29 RASAL2 TUBGCP6 LLGL1 TIAM1 PPP4R2 SSH2 FGD6 PCM1	2.25e-06	199	238	11	M5893
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	APH1B MAP1B MARK1 ZMYM2 SLCO4A1 SMARCAD1 RTN1 DSCAML1 STOX2 NRXN3 KIAA1549L ALMS1 FAM83F NUP210 PHLPP1 ADGRF4 CAMTA1 LMNTD1 CNR2 RASAL2 CACNA1A PDPR AFF2 DTNA EPB41L5 KIAA1549 NR4A3 G2E3 DEPDC1 RABEP1 ZNF641 CAPRIN2 LRIF1 PCM1 GABRA1 EPHA3 GABRA3 FTSJ3	2.90e-07	1414	234	38	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	HDAC9 TDRD9 CHM SYCP1 ARHGAP29 CAMTA1 GPAT2 RASAL2 WDR44 SLC12A6 NRBP1 TDRKH PDPR SYNM GPR143 G2E3 STK31 IFI27 MEIOC CCNB3 CAPRIN2 CD44 GMEB1 ASXL2 MAPK10 TCFL5	5.24e-07	778	234	26	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	APH1B MAP1B MARK1 ZMYM2 SLCO4A1 SMARCAD1 RTN1 STOX2 KIAA1549L ALMS1 NUP210 PHLPP1 CAMTA1 CNR2 RASAL2 CACNA1A PDPR DTNA EPB41L5 KIAA1549 NR4A3 G2E3 DEPDC1 RABEP1 CAPRIN2 LRIF1 PCM1 GABRA1 GABRA3 FTSJ3	2.13e-06	1060	234	30	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000	HDAC9 TTC39B PDE3A MARK1 PCDH12 NRXN3 PCDH18 MRC1 RBM33 APBB2 LMO7 ROBO1 SSH2 TNS1 EPHA3	8.02e-06	348	234	15	gudmap_kidney_adult_Mesangium_Meis_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2	MAP1B DLGAP5 STOX2 VPS52 NRXN3 KIAA1549L UBR5 NUP210 PHLPP1 RASAL2 WDR44 DTNA PCLO EPB41L5 LLGL1 PPP4R2	8.71e-06	395	234	16	Facebase_RNAseq_e8.5_Floor Plate_2500_K2
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000	CYP2C18 TDRD9 CYP11B1 CDH23 DSCAML1 STOX2 VNN1 RRP12 GPAT2 PCDH18 RASAL2 PDPR SYNM DTNA DVL2 G2E3 STK31 IFI27 CTNND1 TNS1 TCFL5 HCFC1 PCM1 EPHA3	1.36e-05	819	234	24	gudmap_developingGonad_e16.5_testes_1000
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	TTC39B EPB41L3 ALMS1 WDR75 NUP210 SYCP1 TAF1 GPAT2 RASAL2 WDR44 TDRKH RELCH PDPR TOP6BL STK31 MEIOC MTOR CAPRIN2 AKAP11 SSH2 LRBA FGD6 TCFL5 HCFC1	1.39e-05	820	234	24	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500	TDRD9 CHM SYCP1 ARHGAP29 CAMTA1 GPAT2 SLC12A6 PDPR SYNM GPR143 G2E3 STK31 LMO7 MAPK10 TCFL5	2.19e-05	379	234	15	gudmap_developingGonad_P2_ovary_500
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	ALMS1 SYCP1 RASAL2 RELCH STK31 CAPRIN2 AKAP11 TCFL5	3.01e-05	110	234	8	gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	MAP1B KIAA1549L ALMS1 UBR5 NUP210 WDR44 PCLO EPB41L5 RABEP1 PPP4R2 CTNND1 FTSJ3	3.25e-05	259	234	12	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000	HDAC9 TTC39B PDE1A PDE3A MARK1 PCDH12 TMEM71 NRP1 NRXN3 PCDH18 RASAL2 MRC1 RBM33 APBB2 ALPK1 IFI27 CERT1 CLOCK LMO7 ROBO1 SSH2 TNS1 FGD6 EPHA3	3.74e-05	872	234	24	gudmap_kidney_adult_Mesangium_Meis_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_200	TDRD9 CHM SYCP1 GPAT2 STK31 MEIOC CCNB3 MAPK10 TCFL5	3.79e-05	147	234	9	gudmap_developingGonad_e18.5_ovary_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	MAP1B ZMYM2 SLCO4A1 RTN1 STOX2 KIAA1549L ALMS1 UBR5 NUP210 PHLPP1 RASAL2 CACNA1A TDRKH PCLO DVL2 EPB41L5 NR4A3 YBX3 SETD2 RABEP1 LRBA MAPK10 FGD6 LRIF1 PCM1 EPHA3	3.79e-05	989	234	26	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	MAP1B SLCO4A1 RTN1 STOX2 KIAA1549L ALMS1 UBR5 NUP210 PHLPP1 RASAL2 TDRKH PCLO EPB41L5 RABEP1 MAPK10 FGD6 PCM1	4.09e-05	498	234	17	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	ALMS1 SYCP1 WDR44 STK31 MEIOC CAPRIN2 AKAP11 FGD6	4.15e-05	115	234	8	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000	GPAT2 RASAL2 RELCH STK31 CAPRIN2 AKAP11 TCFL5	4.29e-05	85	234	7	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_200	TDRD9 CHM SYCP1 GPAT2 G2E3 STK31 MEIOC CCNB3 TCFL5	5.73e-05	155	234	9	gudmap_developingGonad_e16.5_ovary_200
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500	CHM SYCP1 ARHGAP29 GPAT2 RASAL2 WDR44 NRBP1 TDRKH RELCH G2E3 STK31 MEIOC CCNB3 TCFL5	9.38e-05	382	234	14	gudmap_developingGonad_e14.5_ ovary_500
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500	ALMS1 SYCP1 STK31 MEIOC CAPRIN2 FGD6	1.04e-04	68	234	6	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500	TDRD9 CHM SYCP1 ARHGAP29 GPAT2 WDR44 PDPR GPR143 G2E3 STK31 MEIOC CCNB3 MAPK10 TCFL5	1.08e-04	387	234	14	gudmap_developingGonad_e18.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500	TDRD9 CHM SYCP1 ARHGAP29 GPAT2 RASAL2 G2E3 STK31 IFI27 MEIOC CCNB3 CD44 GMEB1 TCFL5	1.08e-04	387	234	14	gudmap_developingGonad_e16.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_100	TDRD9 SYCP1 GPAT2 STK31 MEIOC CCNB3	1.43e-04	72	234	6	gudmap_developingGonad_e18.5_ovary_100
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	HDAC9 CHM ALMS1 SYCP1 ARHGAP29 GPAT2 RASAL2 WDR44 NRBP1 TDRKH RELCH PDPR G2E3 STK31 IFI27 MEIOC CCNB3 CD44 GMEB1 ASXL2 TCFL5	1.47e-04	776	234	21	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2	PDE3A MAP1B MARK1 COL6A5 NRP1 IGSF10 EFEMP1 ARHGAP29 PCDH18 HSPG2 APBB2 CTNND1 TNS1 EPHA3 GABRA3	1.62e-04	453	234	15	GSM777067_500
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#3_top-relative-expression-ranked_1000	TDRD9 SYCP1 GPAT2 G2E3 STK31 TCFL5	1.67e-04	74	234	6	gudmap_developingGonad_e14.5_ testes_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_100	TDRD9 SYCP1 GPAT2 STK31 MEIOC CCNB3	1.67e-04	74	234	6	gudmap_developingGonad_e16.5_ovary_100
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2	HDAC9 APH1B ITGAX RTN1 NRP1 ALMS1 MRC1 NR4A3 DEPDC1 ALPK1 CTNND1 IL1A PLEKHO1 FGD6	1.91e-04	409	234	14	GSM538234_500
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_500	TDRD9 DSCAML1 STOX2 VNN1 GPAT2 PCDH18 RASAL2 SYNM DTNA G2E3 STK31 IFI27 TNS1 EPHA3	1.91e-04	409	234	14	gudmap_developingGonad_e16.5_testes_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000	MAP1B MARK1 ZKSCAN8 WDR81 SLCO4A1 RTN1 STOX2 NRXN3 NUP210 SNRNP40 PHLPP1 TAF1 RASAL2 TDRKH AFF2 DTNA PCLO DVL2 DVL3 EPB41L5 TIAM1 GMEB1 ASXL2 MAPK10	2.20e-04	979	234	24	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000	EPB41L3 ALMS1 SYCP1 WDR44 TOP6BL MEIOC SSH2 LRBA FGD6	2.39e-04	187	234	9	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_200	CHM SYCP1 GPAT2 G2E3 STK31 MEIOC CCNB3 TCFL5	2.42e-04	148	234	8	gudmap_developingGonad_e14.5_ ovary_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	PDE3A HDAC4 MAP1B MARK1 SIX4 EPB41L3 ZBTB37 STOX2 EFEMP1 CAMTA1 PCDH18 MED13 RELCH SZT2 TIAM1 ROBO1 ASXL2 L3MBTL3 GABRA1 EPHA3 GABRA3	2.46e-04	806	234	21	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	PDE3A MAP1B EPB41L3 ZBTB37 MED13 RELCH ASXL2 EPHA3	2.53e-04	149	234	8	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	MAP1B RTN1 KIAA1549L UBR5 NUP210 TDRKH PCLO EPB41L5 SETD2 EPHA3	2.56e-04	231	234	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4
CoexpressionAtlas	DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000	TDRD9 CDH23 DSCAML1 STOX2 VNN1 GPAT2 PCDH18 CNR2 RASAL2 PDPR SYNM DTNA DVL2 G2E3 STK31 IFI27 CD44 CTNND1 TNS1 HCFC1 EPHA3	2.81e-04	814	234	21	gudmap_developingGonad_e18.5_testes_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2	MAP1B RTN1 NRXN3 KIAA1549L NUP210 RASAL2 DTNA PCLO EPB41L5 MAPK10 EPHA3	2.84e-04	279	234	11	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_200	PDE3A MAP1B EPB41L3 RELCH EPHA3	2.90e-04	53	234	5	gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	HDAC9 PDE3A MAP1B MARK1 ZKSCAN8 SIX4 EPB41L3 RTN1 ZBTB37 NRXN3 EFEMP1 MIGA1 PCDH18 MED13 RELCH ROBO1 ASXL2 MAPK10 GABRA1 EPHA3 GABRA3	3.00e-04	818	234	21	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500	HDAC9 TTC39B PDE3A PCDH12 TMEM71 NRP1 PCDH18 MRC1 APBB2 IFI27 LMO7 TNS1 FGD6 EPHA3	3.10e-04	429	234	14	gudmap_kidney_adult_Mesangium_Meis_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500	MAP1B MARK1 SLCO4A1 RTN1 STOX2 NRXN3 NUP210 PHLPP1 RASAL2 TDRKH AFF2 DTNA PCLO EPB41L5 MAPK10	3.15e-04	482	234	15	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	PDE3A MAP1B MARK1 ZKSCAN8 EPB41L3 ZBTB37 MIGA1 MED13 RELCH ASXL2 EPHA3 GABRA3	3.18e-04	330	234	12	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000	TDRD9 STOX2 VNN1 RRP12 SYCP1 GPAT2 PCDH18 RASAL2 PDPR SYNM DTNA DVL2 EPB41L5 G2E3 STK31 IFI27 CTNND1 TNS1 TCFL5 HCFC1 PCM1	3.20e-04	822	234	21	gudmap_developingGonad_e14.5_ testes_1000
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000	TTC39B GLT1D1 SIX4 ALMS1 WDR75 UBR5 NUP210 SYCP1 TAF1 WDR44 CCDC14 TDRKH G2E3 STK31 MEIOC MTOR CAPRIN2 AKAP11 EIF3G FGD6 HCFC1	3.20e-04	822	234	21	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_500	GPAT2 NRBP1 TDRKH RELCH STK31 MEIOC TCFL5	3.37e-04	118	234	7	gudmap_developingGonad_e14.5_ ovary_500_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000	MAP1B SIX4 EPB41L3 SNRNP40 MIGA1 NR4A3 ASXL2 GABRA1	3.61e-04	157	234	8	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	SYNRG TMEM42 MAP1B MARK1 WDR81 RTN1 STOX2 NRXN3 KIAA1549L ALMS1 NUP210 PHLPP1 RASAL2 CACNA1A TDRKH DTNA PCLO EPB41L5 KDM7A MAPK10 EPHA3 PHLPP2	3.78e-04	893	234	22	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500	TTC39B MAP1B RTN1 NRXN3 KIAA1549L NUP210 PHLPP1 RASAL2 TDRKH AFF2 DTNA PCLO EPB41L5 KDM7A MAPK10	4.26e-04	496	234	15	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500
CoexpressionAtlas	dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000	PDE1A CYP11B1 PCDH12 TRDN NRP1 STOX2 VNN1 SVIL SYCP1 NAV3 ARHGAP29 RASAL2 MRC1 HSPG2 FLT4 AFF2 APBB2 SHANK3 ROBO1 KDM7A SSH2	4.67e-04	846	234	21	gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_1000	MAP1B EPB41L3 RTN1 NR4A3 LMO7 MAPK10	4.84e-04	90	234	6	gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k4
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_200	GPAT2 STK31 MEIOC TCFL5	5.14e-04	34	234	4	gudmap_developingGonad_e18.5_ovary_200_k2
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_1000	HDAC9 ALMS1 GPAT2 WDR44 NRBP1 TDRKH RELCH MEIOC TCFL5	5.57e-04	210	234	9	gudmap_developingGonad_e14.5_ ovary_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#5	TTC39B TMEM42 RTN1 STOX2 NRXN3 PHLPP1 RASAL2 DTNA MAPK10	5.97e-04	212	234	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	HDAC9 PDE3A MAP1B MARK1 ZKSCAN8 SIX4 EPB41L3 RTN1 EFEMP1 MIGA1 PCDH18 MED13 RELCH ABHD2 ROBO1 ASXL2 MAPK10 L3MBTL3 EPHA3 GABRA3	6.40e-04	806	234	20	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	TTC39B SIX4 ALMS1 WDR75 UBR5 RRP12 NUP210 SYCP1 TAF1 RASAL2 TDRKH RELCH G2E3 STK31 MTOR CAPRIN2 AKAP11 EIF3G TCFL5 FTSJ3	6.80e-04	810	234	20	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_1000	GPAT2 NRBP1 TDRKH STK31 MEIOC TCFL5	7.20e-04	97	234	6	gudmap_developingGonad_e18.5_ovary_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#4	MAP1B RTN1 NUP210 TDRKH PCLO EPB41L5	7.20e-04	97	234	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K4
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500	PCDH12 TRDN NRP1 VNN1 NAV3 ARHGAP29 RASAL2 MRC1 HSPG2 FLT4 APBB2 ROBO1 SSH2	7.24e-04	414	234	13	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	PDE3A HDAC4 MAP1B MARK1 EPB41L3 ZBTB37 MED13 RELCH ASXL2 EPHA3 GABRA3	7.25e-04	312	234	11	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	PDE3A MAP1B MARK1 ZKSCAN8 EPB41L3 MIGA1 MED13 RELCH ASXL2 L3MBTL3 EPHA3 GABRA3	8.53e-04	369	234	12	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#4	HDAC9 PDE1A RTN1 KIAA1549L NUP210 CACNA1A DTNA MAPK10 EPHA3	8.55e-04	223	234	9	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K4
CoexpressionAtlas	DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#1_top-relative-expression-ranked_1000	TDRD9 GPAT2 G2E3 STK31	8.73e-04	39	234	4	gudmap_developingGonad_e18.5_testes_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	MAP1B RTN1 STOX2 NRXN3 NUP210 TAF1 TDRKH PCLO EPB41L5	9.11e-04	225	234	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000	TDRD9 CHM VNN1 SYCP1 ARHGAP29 CAMTA1 GPAT2 SLC12A6 NRBP1 TDRKH PDPR SYNM GPR143 G2E3 STK31 LMO7 GMEB1 MAPK10 TCFL5	9.32e-04	770	234	19	gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000	MAP1B EPB41L3 TMEM71 RTN1 EFEMP1 BRAF ADGRF4 UPK3A MED13 WDR44 PAPPA2 PRUNE2 RELCH SYNM DTNA NR4A3 LMO7 MAPK10 TNS1	9.61e-04	772	234	19	gudmap_developingLowerUrinaryTract_P1_bladder_1000_J
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	MAP1B DLGAP5 ZKSCAN8 SLCO4A1 BPTF NUP210 TAF1 TDRKH PDPR PCLO EPB41L5 CLOCK LLGL1 PPP4R2 ASXL2 STAG2	9.74e-04	595	234	16	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	kidney_adult_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	NRP1 ARHGAP29 APBB2 ALPK1 IFI27 CLOCK KDM7A	1.02e-03	142	234	7	gudmap_kidney_adult_Podocyte_MafB_k2_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_100	SYCP1 GPAT2 STK31 MEIOC TCFL5	1.05e-03	70	234	5	gudmap_developingGonad_e14.5_ ovary_100
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000	HDAC9 TDRD9 SYCP1 ARHGAP29 WDR44 CCNB3 CAPRIN2 CD44 ASXL2	1.06e-03	230	234	9	gudmap_developingGonad_e18.5_ovary_1000_k5
CoexpressionAtlas	dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000	HDAC9 MAP1B NFASC EPB41L3 RTN1 CAMTA1 TDRKH PCLO APBB2 MAPK10	1.08e-03	278	234	10	gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500	PDE3A MAP1B ZKSCAN8 MED13 G2E3 CERT1 ASXL2 L3MBTL3 GABRA3	1.10e-03	231	234	9	gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1
CoexpressionAtlas	SC UCB CD34+Z_vs_SC blastocyst-Confounder_removed-fold2.0_adjp0.05	WDR44 PRICKLE1 GPR143	1.12e-03	19	234	3	PCBC_ratio_SC UCB CD34+Z_vs_SC blastocyst_cfr-2X-p05
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_100	TDRD9 SYCP1 CCNB3	1.12e-03	19	234	3	gudmap_developingGonad_e18.5_ovary_100_k1
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2	RTN1 NRXN3 NUP210 TDRKH DTNA EPB41L5 MAPK10	1.15e-03	145	234	7	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K2
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRP1 ALMS1 ARHGAP29 RASAL2 HSPG2 FLT4 PDPR PRICKLE1 PCDHB14 APBB2 SHANK3 ROBO1	2.94e-10	181	238	12	4df7972f88117108698efd06b124b232f8588981
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRP1 ALMS1 ARHGAP29 RASAL2 HSPG2 FLT4 PDPR PRICKLE1 PCDHB14 APBB2 SHANK3 ROBO1	2.94e-10	181	238	12	cbb530566893281289026bfd93adf721decd4ca3
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALMS1 ARHGAP29 RASAL2 HSPG2 FLT4 PRICKLE1 RBM33 APBB2 SHANK3 GMEB1 ROBO1	3.25e-09	177	238	11	8ef41ee5d63737b810ad7371b0437625e7e1badf
ToppCell	droplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR81 TRDN TECPR2 NUP210 PCDHB14 NRG2 CERT1 CLOCK IL1A FGD6	2.29e-08	166	238	10	35db3022c33d6f8bb6587d9eec89a7cccb70271a
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 PDE3A TDRD9 MAP1B TMEM71 TRDN TECPR2 SYNM DTNA NR4A3	5.77e-08	183	238	10	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE1A MAP1B ARHGAP29 SLC5A12 RASAL2 PRICKLE1 SYNM APBB2 KIAA1549 LMO7	9.98e-08	194	238	10	cf7f232827945fbafd2c298c08a799ab916c2472
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	STOX2 SEMA3B ARHGAP29 APBB2 IFI27 SHANK3 STK33 TNS1 FGD6 EPHA3	1.33e-07	200	238	10	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	STOX2 SEMA3B ARHGAP29 APBB2 IFI27 SHANK3 STK33 TNS1 FGD6 EPHA3	1.33e-07	200	238	10	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	STOX2 SEMA3B ARHGAP29 APBB2 IFI27 SHANK3 STK33 TNS1 FGD6 EPHA3	1.33e-07	200	238	10	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	STOX2 SEMA3B ARHGAP29 APBB2 IFI27 SHANK3 STK33 TNS1 FGD6 EPHA3	1.33e-07	200	238	10	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	STOX2 SEMA3B ARHGAP29 APBB2 IFI27 SHANK3 STK33 TNS1 FGD6 EPHA3	1.33e-07	200	238	10	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	STOX2 SEMA3B ARHGAP29 APBB2 IFI27 SHANK3 STK33 TNS1 FGD6 EPHA3	1.33e-07	200	238	10	7136936d05ab344a560cf159684c881063b5430d
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B STOX2 EFEMP1 MRC1 FLT4 SYNM PCLO STK33 SLC24A1	3.87e-07	172	238	9	1bad7b19724e1b53ace7e05644215334c9f43910
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE1A PDE3A MAP1B MARK1 NFASC GPAT2 CACNA1A SYNM EPHA3	4.48e-07	175	238	9	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	MAP1B NFASC DSCAML1 NRP1 RASAL2 CACNA1A APBB2 MAPK10 EPHA3	6.23e-07	182	238	9	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH12 NRP1 IGSF10 MRC1 HSPG2 FLT4 PRICKLE1 SHANK3 TIAM1	6.23e-07	182	238	9	b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCell	ILEUM-inflamed-(7)_Lymphatics\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	STOX2 EFEMP1 ARHGAP29 FLT4 SYNM PCLO SHANK3 SLC24A1 TNS1	7.14e-07	185	238	9	d711dd2e91cfee723dae1ccb2b910b8cf3becc3b
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B RTN1 NRXN3 CAMTA1 PRUNE2 CACNA1A PCLO GABRA1 JPH3	7.47e-07	186	238	9	d1d01ce46e62944aa9864eda47e8401b5f0d2bdc
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	PDE1A PDE3A MAP1B MARK1 NFASC NAV3 NR4A3 MAPK10 EPHA3	7.47e-07	186	238	9	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	HDAC9 GLT1D1 CDH23 ITGAL ITGAX RTN1 SIRPD VNN1 SSH2	8.54e-07	189	238	9	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PDE1A EFEMP1 LRRIQ1 MRC1 FLT4 SYNM PCLO SLC24A1 TNS1	9.73e-07	192	238	9	d43caf42ec744e895137f31ef65a990e250669d2
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-immature_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NFASC PCDH12 NRP1 ARHGAP29 HSPG2 FLT4 SYNM SHANK3 CTNND1	9.73e-07	192	238	9	5af3b2b38495e925497c48f605d618bbf970965d
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STOX2 EFEMP1 ARHGAP29 MRC1 FLT4 SYNM SHANK3 SLC24A1 TNS1	1.02e-06	193	238	9	bd0027fa97de41ae22ff64a61c8e217496f122ca
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	SYNRG ZXDA BPTF MIGA1 MED13 G2E3 CLOCK ASXL2 STAG2	1.02e-06	193	238	9	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1A MARK1 IGSF10 NRXN3 EFEMP1 SYCP1 GPAT2 PCDH18 EPHA3	1.06e-06	194	238	9	7942bc83c1bdca687795b91aa232824d603f9b09
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCDH12 RTN1 NRP1 ARHGAP29 SLC5A12 LMNTD1 RASAL2 FLT4 PRICKLE1	1.06e-06	194	238	9	fc40ab57be3a15c043e3414c2c678c1dc52207c8
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1A MARK1 IGSF10 NRXN3 EFEMP1 SYCP1 GPAT2 PCDH18 EPHA3	1.06e-06	194	238	9	415801a3dfacf05f2b603fb424df3d045190a812
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1A MARK1 IGSF10 NRXN3 EFEMP1 SYCP1 GPAT2 PCDH18 EPHA3	1.06e-06	194	238	9	256cb33ec90328f2704921fb0fe0fd9812e138b0
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCDH12 RTN1 NRP1 ARHGAP29 SLC5A12 LMNTD1 RASAL2 FLT4 PRICKLE1	1.06e-06	194	238	9	50fa7c7940b113427c87fbdb9057fef8e1ce52c5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 CDH23 ITGAL ITGAX RTN1 MRC1 TIAM1 ARHGAP45 PLEKHO1	1.06e-06	194	238	9	badefcec2af86cbcd97305f4843e84db0f3ebc66
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A DSCAML1 PCLO EPB41L5 SLC12A1 LMO7 STK33 LRBA MAPK10	1.11e-06	195	238	9	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	Endothelial_cells-Endothelial-B\|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id	PDE1A MAP1B PCDH12 STOX2 EFEMP1 MRC1 FLT4 SYNM SLC24A1	1.15e-06	196	238	9	36f95f9ef74eb951e41ef46fd136ceaef45208fc
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE1A PCDH12 EFEMP1 ARHGAP29 MRC1 FLT4 SYNM SLC24A1 TNS1	1.26e-06	198	238	9	99d6a64f3410dae3019161feef20a8f06081a24b
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRP1 STOX2 RASAL2 MRC1 HSPG2 FLT4 PRICKLE1 APBB2 IL1A	1.26e-06	198	238	9	f0f1816a0ed3ae8207442602f5cbe4de0382e4b3
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	PCDH12 NRP1 EFEMP1 KIDINS220 ARHGAP29 FLT4 APBB2 TIAM1 CTNND1	1.31e-06	199	238	9	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	Striatum-Neuronal\|Striatum / BrainAtlas - Mouse McCarroll V32	MAP1B RTN1 NRXN3 CAMTA1 PCLO SYNGR3 GABRA1 JPH3 GABRA2	1.37e-06	200	238	9	c888fd487990cad482a4ca47601cdebc0ca3f3ce
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PCDH12 PLEKHG5 NRP1 BPTF UBR5 ARHGAP29 CTNND1 PLEKHO1 FGD6	1.37e-06	200	238	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 ITGAX RTN1 CD101 UPK3A MRC1 DTNA CTNND1	2.11e-06	157	238	8	e9d0300361b06aec3c216f8af15f09e14b12a4da
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HDAC9 ITGAX RTN1 CD101 UPK3A MRC1 DTNA CTNND1	2.22e-06	158	238	8	e9657d8960d499832f9f9b45b5a6f4388551b7e1
ToppCell	Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-\|Striatum / BrainAtlas - Mouse McCarroll V32	SLCO4A1 CDH23 ITGAX CNR2 SLC5A10 IL1A	2.82e-06	74	238	6	e89506bd854a43b80f839ace36f7a3eaa8437215
ToppCell	Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)\|Striatum / BrainAtlas - Mouse McCarroll V32	SLCO4A1 CDH23 ITGAX CNR2 SLC5A10 IL1A	2.82e-06	74	238	6	0dbce0b36eaf0c7a8b623478c85d1cac82c6693a
ToppCell	Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)\|Striatum / BrainAtlas - Mouse McCarroll V32	SLCO4A1 CDH23 ITGAX CNR2 SLC5A10 IL1A	2.82e-06	74	238	6	093575ea862f3724d236817f04d98cc06b8addf0
ToppCell	Striatum-Hematopoietic-MICROGLIA\|Striatum / BrainAtlas - Mouse McCarroll V32	SLCO4A1 CDH23 ITGAX CNR2 SLC5A10 IL1A	2.82e-06	74	238	6	89effada90fbfef1844a905d3f82e9d16666eea5
ToppCell	Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--\|Striatum / BrainAtlas - Mouse McCarroll V32	SLCO4A1 CDH23 ITGAX CNR2 SLC5A10 IL1A	2.82e-06	74	238	6	b14a950b90791a4cc5ffd29eb75a524abdd382da
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RTN1 PAPPA2 CACNA1A C22orf42 PCLO HHLA1 GPR119 GABRA2	3.82e-06	170	238	8	6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH12 NRXN3 PCDH18 PRICKLE1 SHANK3 TMEM132E FGD6 EPHA3	4.17e-06	172	238	8	073a503dc922e3e3ac3528e249b0f8b74402110b
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH12 NRP1 CNR2 MRC1 HSPG2 FLT4 PCDHB14 TIAM1	4.17e-06	172	238	8	a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCDH12 STOX2 ARHGAP29 MRC1 FLT4 SYNM SLC24A1 JPH3	4.35e-06	173	238	8	7dc988fc0ba29990567bf1bcdeb3faeeee507eb1
ToppCell	CF-Myeloid-Neutrophil\|Myeloid / Disease state, Lineage and Cell class	GLT1D1 ATG2A ITGAX TMEM71 TECPR2 SVIL SLC12A6 ALPK1	4.73e-06	175	238	8	8020c3a34f77e68e8149f87481fb1dddd2ac675e
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH12 NRP1 CNR2 MRC1 HSPG2 FLT4 PCDHB14 TIAM1	4.94e-06	176	238	8	3494ffa8555e6edf4b1250e10434bae9b73ec845
ToppCell	droplet-Liver-Npc-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH12 NRP1 CNR2 MRC1 HSPG2 FLT4 PCDHB14 TIAM1	4.94e-06	176	238	8	d43f6b7828b98e1dab7b726a5f99499d65a7db80
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 EPB41L3 NRP1 IGSF10 STOX2 NRXN3 LMO7 LRBA	5.15e-06	177	238	8	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B NFASC COL6A5 DNAH9 PRUNE2 CACNA1A PCLO GABRA3	5.37e-06	178	238	8	30ca37f70d267cc9b40ca3e211f16d30360c3e6b
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	PDE1A PDE3A MAP1B SVIL PRUNE2 SYNM DTNA TNS1	5.82e-06	180	238	8	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	AT1_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	HDAC9 SEMA3B HSPG2 APBB2 EPB41L5 IFI27 LMO7 TNS1	5.82e-06	180	238	8	2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGAL ITGAX RTN1 NRXN3 PRUNE2 CACNA1A CD44 ARHGAP45	5.82e-06	180	238	8	6ac62bf1251978c8c12e715f7b73144fca619794
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B NFASC RTN1 IGSF10 KIAA1549L ATMIN DVL3 KIAA1549	6.07e-06	181	238	8	ad30c01290fb98adbd0caed301a584761212c977
ToppCell	3'_v3-bone_marrow-Mast-Mast_cells\|bone_marrow / Manually curated celltypes from each tissue	PDE3A SIGLEC8 FAM83F CCR3 HSPG2 AFF2 KIAA1549 NR4A3	6.07e-06	181	238	8	30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPB41L3 DSCAML1 NRXN3 EFEMP1 SEMA3B HSPG2 EPB41L5 LMO7	6.07e-06	181	238	8	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 PDE1A NAV3 ARHGAP29 DTNA EPB41L5 ROBO1 EPHA3	6.07e-06	181	238	8	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B NFASC RTN1 IGSF10 KIAA1549L ATMIN DVL3 KIAA1549	6.07e-06	181	238	8	4e81ec1580e9acb22c32c465eb46f83d1e9e424e
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	MAP1B NFASC DSCAML1 NRP1 RASAL2 CACNA1A APBB2 EPHA3	6.07e-06	181	238	8	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B NFASC RTN1 IGSF10 KIAA1549L ATMIN DVL3 KIAA1549	6.07e-06	181	238	8	3a3268a4dff8ffcb79e09f46490e138c96f8d916
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 PDE1A NAV3 ARHGAP29 DTNA EPB41L5 ROBO1 EPHA3	6.07e-06	181	238	8	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	COVID-19-Heart-EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE1A PDE3A MAP1B NFASC GPAT2 APBB2 SHANK3 EPHA3	6.32e-06	182	238	8	e67f3234165199085c793915ebb1f9bbd845e933
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	MAP1B NFASC DSCAML1 NRP1 GPAT2 RASAL2 APBB2 EPHA3	6.58e-06	183	238	8	273db6a3b00a93ca852498471187b642b5368185
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	MAP1B NFASC DSCAML1 NRP1 GPAT2 RASAL2 APBB2 EPHA3	6.58e-06	183	238	8	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B NFASC RTN1 DNAH9 PAPPA2 PRUNE2 PCLO GPR119	6.84e-06	184	238	8	3da93e7d8b62463e307cc0425c47dbd3bef66799
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTN1 NRXN3 PRUNE2 CACNA1A PCLO SYNGR3 GABRA1 JPH3	6.84e-06	184	238	8	7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH12 DCST1 RASAL2 MRC1 HSPG2 FLT4 PRICKLE1 PCDHB14	7.12e-06	185	238	8	742350093d90f96735dc73e3360cdd749bae63fd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MAP1B MARK1 NFASC NRXN3 RASAL2 APBB2 ROBO1	7.12e-06	185	238	8	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDE1A STOX2 NRXN3 ARHGAP29 FLT4 SYNM PCLO SHANK3	7.12e-06	185	238	8	f9f48251bc33eb6bf2cff580d1a3207d21450aa0
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	PDE1A MAP1B NFASC NRP1 GPAT2 RASAL2 APBB2 EPHA3	7.12e-06	185	238	8	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MAP1B MARK1 NFASC NRXN3 RASAL2 APBB2 ROBO1	7.12e-06	185	238	8	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	COVID_vent-Myeloid-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HDAC9 EPB41L3 ITGAX RTN1 UPK3A MRC1 ROBO1 PLEKHO1	7.41e-06	186	238	8	63a5cdd3f60681762a218be32db84be8f29b88fd
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPB41L3 DSCAML1 NRXN3 EFEMP1 SEMA3B HSPG2 EPB41L5 LMO7	7.41e-06	186	238	8	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE3A MAP1B MARK1 PCDH18 AFF2 SYNM APBB2 TNS1	7.41e-06	186	238	8	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	COVID_vent-Myeloid-Dendritic-cDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HDAC9 EPB41L3 ITGAX RTN1 UPK3A MRC1 ROBO1 PLEKHO1	7.41e-06	186	238	8	39457a7b43537f2c3e221f9375c95d4515424d7d
ToppCell	Control-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	EPB41L3 SEMA3B APBB2 EPB41L5 IFI27 LMO7 TNS1 PLEKHO1	7.70e-06	187	238	8	3a032432f780525f4f4c2a358897d9989b1ecae7
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STOX2 CNR2 RASAL2 HSPG2 FLT4 PRICKLE1 SHANK3 TIAM1	8.01e-06	188	238	8	0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TDRD9 MAP1B LRRIQ1 SVIL PRUNE2 SYNM DTNA PLEKHO1	8.33e-06	189	238	8	63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 PDE3A MAP1B TMEM71 TRDN SYNM DTNA EPHA3	8.65e-06	190	238	8	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLGAP5 LRRIQ1 CCDC14 MUC16 DEPDC1 MUC12 PITPNM1 PCM1	8.65e-06	190	238	8	0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLGAP5 LRRIQ1 CCDC14 MUC16 DEPDC1 MUC12 PITPNM1 PCM1	8.65e-06	190	238	8	05455775845f4ded5c27e7b83242078d23162aaf
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLCO4A1 ITGAX TRDN CCR3 PITPNM1 ZNF641 JPH3	8.68e-06	136	238	7	186be8e1595608004b8216892cb9c7a7f31fbb4d
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PDE3A NFASC SEMA3B MUC16 MEIOC MUC22 GABRA1	8.68e-06	136	238	7	27a41463e6f16deb5b1d4f17fefded9959038c07
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE3A NFASC SEMA3B MUC16 MEIOC MUC22 GABRA1	8.68e-06	136	238	7	88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPB41L3 NRP1 STOX2 SLC5A12 PRUNE2 SLC5A10 PRICKLE1 DTNA	8.99e-06	191	238	8	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	PDE1A PDE3A MAP1B MARK1 NFASC EFEMP1 MAPK10 EPHA3	8.99e-06	191	238	8	78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GLT1D1 ITGAX TMEM71 RTN1 SLC12A6 TIAM1 SSH2 ARHGAP45	8.99e-06	191	238	8	47a2afc4102199b4bc76bd01b2967c8016186462
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPB41L3 NRP1 STOX2 SLC5A12 PRUNE2 SLC5A10 PRICKLE1 DTNA	8.99e-06	191	238	8	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	367C-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PDE1A MAP1B EFEMP1 MRC1 FLT4 SYNM PCLO SLC24A1	9.34e-06	192	238	8	5e709c0714e8eba27e03a6def0544256bedb3ced
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PDE1A EFEMP1 PRUNE2 MRC1 FLT4 SYNM PCLO SLC24A1	9.34e-06	192	238	8	b016e229300c183e14c0e2bba494bf49c7899112
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PDE1A EFEMP1 PRUNE2 MRC1 FLT4 SYNM PCLO SLC24A1	9.34e-06	192	238	8	ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9
ToppCell	367C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PDE1A MAP1B EFEMP1 MRC1 FLT4 SYNM PCLO SLC24A1	9.34e-06	192	238	8	5f4f44f15d3a2846981e68296643a4634930a211
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1A ARHGAP29 LMNTD1 RASAL2 PRICKLE1 APBB2 KIAA1549 LMO7	9.34e-06	192	238	8	35f7926628a967f85b26371e795a1b93c6f103ab
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH12 NRP1 RASAL2 MRC1 HSPG2 FLT4 PRICKLE1 IL1A	9.34e-06	192	238	8	d525f7f088a53110912600a7c9f6d33b9270d534
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	EPB41L3 NRP1 SVIL SLC5A12 NSMCE2 SSH2 LRBA MAPK10	9.34e-06	192	238	8	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH12 NRP1 RASAL2 MRC1 HSPG2 FLT4 PRICKLE1 IL1A	9.34e-06	192	238	8	2bfac6b3956265205ca47d06888851ed68b65999
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE1A DRG2 WDR27 E4F1 STK31 CCNB3 NAXD	9.55e-06	138	238	7	611fe0fb284e12678f9c47a0bdbfc367a93c52b3
Computational	Genes in the cancer module 135.	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B2	1.72e-05	25	144	5	MODULE_135
Computational	Cytochrome P450.	CYP3A7 CYP2C18 CYP2D6 CYP3A4	2.79e-05	14	144	4	MODULE_106
Drug	Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A	MAP1B PCDH12 NAV3 PAPPA2 DTNA DVL3 APBB2 NRG2 ELP1 ALPK1 CERT1 TNS1 PCM1	1.52e-07	196	237	13	6571_DN
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ZMYM2 HSPG2 DTNA ABHD2 EPB41L5 GPR143 ALPK1 TEP1 IFI27 CERT1 CD44 HCFC1	1.02e-06	195	237	12	4398_DN
Drug	Zolpidem	GABRA1 GABRA2 GABRA3	1.11e-06	3	237	3	DB00425
Drug	CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A	PDE6C NRXN3 CD101 NAV3 TDRKH DTNA NRG2 ELP1 TNS1 PLEKHO1 VPS53 HCFC1	1.14e-06	197	237	12	4557_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A	PDE6C CYP3A4 PAOX NRXN3 CD101 NAV3 ABHD2 ELP1 TIAM1 SYNGR3 ARHGAP45 VPS53	1.20e-06	198	237	12	4550_DN
Drug	hydroxyzine	CYP2D6 KCNH3 HRH4 GABRA1 GABRA2	1.21e-06	19	237	5	CID000003658
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; PC3; HT_HG-U133A	NUP210 NAV3 EXOC7 RASAL2 SLC12A6 DTNA ABHD2 TEP1 PITPNM1 RABEP1 GMEB1 HCFC1	1.27e-06	199	237	12	4209_DN
Drug	Flumazenil	GABRA1 GABRA2 GABRA3	4.42e-06	4	237	3	DB01205
Drug	alprazolam	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 DTNA MTOR GABRA1 GABRA2 GABRA3	6.07e-06	193	237	11	CID000002118
Drug	Dubinidine [22964-77-8]; Up 200; 14.6uM; PC3; HT_HG-U133A	NFASC PCDH12 ITGAL VNN1 CNR2 PRUNE2 FLT4 EPB41L5 GPR143 ALPK1 KDM7A	6.38e-06	194	237	11	5774_UP
Drug	Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A	SEMA3B PAPPA2 KRT2 TDRKH AFF2 DTNA PCLO SLC24A1 VPS53 GABRA1 GABRA2	7.03e-06	196	237	11	5704_UP
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	CYP3A4 EXOC7 CNR2 SLC12A6 APBB2 GPR143 TOP6BL TEP1 SYNGR3 TNS1 EPHA3	7.03e-06	196	237	11	3830_DN
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; PC3; HT_HG-U133A	SYNRG PDE6C PCDH12 CD101 AFF2 DTNA APBB2 TIAM1 SYNGR3 TNS1 GABRA2	7.38e-06	197	237	11	4673_DN
Drug	Tolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; PC3; HT_HG-U133A	CYP3A4 MARK1 SIGLEC8 ITGAL NRXN3 CD101 RRP12 SYCP1 PAPPA2 FLT4 MAPK10	7.38e-06	197	237	11	4088_UP
Drug	hexobarbital	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 UGT2B4 GABRA1 GABRA2	7.53e-06	127	237	9	CID000003608
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A	ASXL1 HDAC4 EXOC7 PAPPA2 HSPG2 DTNA DVL2 APBB2 ELP1 TEP1 PLEKHO1	7.75e-06	198	237	11	3869_DN
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RRP12 SVIL TAF1 EXOC7 DRG2 PCLO DVL2 TEP1 MAPK10 SLC24A1 HCFC1	7.75e-06	198	237	11	4133_DN
Drug	Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; HL60; HT_HG-U133A	PDE6C CYP3A4 PDZD7 EXOC7 CACNA1A FLT4 DVL2 NRG2 PITPNM1 VPS53 PHLPP2	8.13e-06	199	237	11	2725_DN
Drug	3-nitropropionic acid; Down 200; 10uM; PC3; HT_HG-U133A	HDAC9 HDAC4 VNN1 TAF1 EXOC7 RASAL2 PAPPA2 APBB2 PITPNM1 GMEB1 VPS53	8.52e-06	200	237	11	6407_DN
Drug	Eszopiclone	GABRA1 GABRA2 GABRA3	1.10e-05	5	237	3	DB00402
Drug	Zopiclone	GABRA1 GABRA2 GABRA3	1.10e-05	5	237	3	DB01198
Drug	hyodeoxycholic acid	CYP2D6 CYP3A4 UGT2B4	1.10e-05	5	237	3	ctd:C010471
Drug	Lorazepam	GABRA1 GABRA2 GABRA3	1.10e-05	5	237	3	ctd:D008140
Drug	triazolam	CYP3A7 CYP2C18 CYP3A4 GABRA1 GABRA2 GABRA3	2.03e-05	54	237	6	CID000005556
Drug	Meprobamate	GABRA1 GABRA2 GABRA3	2.18e-05	6	237	3	DB00371
Drug	Quazepam	GABRA1 GABRA2 GABRA3	3.78e-05	7	237	3	DB01589
Drug	telithromycin	CYP2D6 CYP3A4 IL1A	3.78e-05	7	237	3	ctd:C106791
Drug	5-hydroxydiclofenac	CYP2C18 CYP2D6 CYP3A4	3.78e-05	7	237	3	ctd:C117715
Drug	Ebselen [60940-34-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A	PAOX KIDINS220 EXOC7 FLT4 APBB2 TIAM1 GMEB1 ARHGAP45 PCM1 EPHA3	3.99e-05	195	237	10	3458_DN
Drug	Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A	CYP3A4 CHM SEMA3B RASAL2 CACNA1A PCLO ALPK1 PITPNM1 RABEP1 PCM1	3.99e-05	195	237	10	5093_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A	MAP1B ZMYM2 CHM ALMS1 BRAF DVL2 RABEP1 TNS1 VPS53 PCM1	3.99e-05	195	237	10	3755_DN
Drug	Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	CYP3A4 PCDH12 PAOX SEMA3B EXOC7 PAPPA2 APBB2 LLGL1 ARHGAP45 PCM1	4.17e-05	196	237	10	5322_UP
Drug	Levonordefrin [829-74-3]; Down 200; 21.8uM; HL60; HT_HG-U133A	HDAC9 PDE6C PDZD7 PCDH12 FLT4 DTNA DVL2 NRG2 ELP1 TNS1	4.17e-05	196	237	10	2710_DN
Drug	Sulmazole [73384-60-8]; Up 200; 14uM; MCF7; HT_HG-U133A	APH1B ZMYM2 CD101 EXOC7 PAPPA2 HSPG2 APBB2 IFI27 PITPNM1 MAPK10	4.17e-05	196	237	10	4127_UP
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	PDE6C CHM DTNA ABHD2 APBB2 ALPK1 PITPNM1 TIAM1 PCM1 GABRA2	4.17e-05	196	237	10	4227_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	MAP1B ALMS1 SVIL TAF1 ABHD2 TOP6BL ALPK1 CD44 PLEKHO1 GABRA2	4.35e-05	197	237	10	6011_DN
Drug	Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A	SREBF1 PAOX CD101 HSPG2 ALPK1 TEP1 TIAM1 KDM7A TNS1 VPS53	4.35e-05	197	237	10	4547_DN
Drug	S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; HL60; HT_HG-U133A	SIGLEC8 PCDH12 BRS3 PRUNE2 ABHD2 DVL2 NRG2 NR4A3 CD44 SLC24A1	4.35e-05	197	237	10	3094_UP
Drug	Ethisterone [434-03-7]; Up 200; 12.8uM; HL60; HT_HG-U133A	SIGLEC8 EXOC7 HSPG2 SZT2 DVL2 NRG2 SETD2 CAPRIN2 CTNND1 MUC6	4.35e-05	197	237	10	2366_UP
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; PC3; HT_HG-U133A	DCHS2 CYP11B2 EXOC7 PAPPA2 PRUNE2 AFF2 DTNA APBB2 TNS1 JPH3	4.35e-05	197	237	10	6759_UP
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; MCF7; HT_HG-U133A	PCDH12 NRP1 TECPR2 PRUNE2 AFF2 ABHD2 IFI27 SETD2 LLGL1 PCM1	4.35e-05	197	237	10	3836_UP
Drug	Estrone [53-16-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A	NFASC KIDINS220 CD101 SEMA3B DNAH9 SZT2 NRG2 PITPNM1 TNS1 GABRA2	4.35e-05	197	237	10	4993_UP
Drug	Capsaicin [404-86-4]; Up 200; 13uM; PC3; HT_HG-U133A	SIGLEC8 NFASC ITGAL TECPR2 SLC5A12 CNR2 FLT4 DTNA VPS53 MUC6	4.54e-05	198	237	10	4612_UP
Drug	Sulfisoxazole [127-69-5]; Down 200; 15uM; PC3; HT_HG-U133A	NRP1 CD101 RRP12 DTNA ABHD2 APBB2 TOP6BL TIAM1 SYNGR3 VPS53	4.54e-05	198	237	10	4661_DN
Drug	Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A	CYP2C18 BRAF SVIL TAF1 EXOC7 CACNA1A FLT4 NRG2 ALPK1 GABRA2	4.54e-05	198	237	10	6270_UP
Drug	Ethamsylate [2624-44-4]; Down 200; 15.2uM; PC3; HT_HG-U133A	TECPR2 TAF1 EXOC7 CACNA1A HSPG2 ABHD2 DVL3 TEP1 GMEB1 HCFC1	4.54e-05	198	237	10	4576_DN
Drug	Ioversol [87771-40-2]; Up 200; 5uM; MCF7; HT_HG-U133A	SYNRG MAP1B SVIL CNR2 EPB41L5 NRG2 TEP1 LLGL1 SLC24A1 VPS53	4.54e-05	198	237	10	5326_UP
Drug	Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A	SYNRG CYP3A4 CHM PAOX SEMA3B SLC12A6 TDRKH DTNA IFI27 CAPRIN2	4.54e-05	198	237	10	6841_DN
Drug	Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A	IMPG1 MAP1B MARK1 TECPR2 PAPPA2 TDRKH DTNA IL1A SLC24A1 VPS53	4.74e-05	199	237	10	3202_UP
Drug	Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A	SIGLEC8 PAOX SEMA3B MINAR1 CNR2 NRG2 VPS53 MUC6 JPH3 GABRA2	4.74e-05	199	237	10	3017_DN
Drug	N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; MCF7; HT_HG-U133A	KIAA1549L RRP12 SLC5A12 RASAL2 DVL3 CD44 MAPK10 SLC24A1 MUC6 GABRA2	4.74e-05	199	237	10	6462_UP
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; PC3; HT_HG-U133A	APH1B PAOX TECPR2 NUP210 SEMA3B NAV3 ATG2B DVL2 ALPK1 TNS1	4.74e-05	199	237	10	4278_DN
Drug	AC1N65YL	CYP2D6 CYP3A4 GABRA1 GABRA2	4.86e-05	20	237	4	CID004229818
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	MAP1B PAOX ALMS1 CNR2 SZT2 DVL3 ELP1 ALPK1 MTOR CD44	4.95e-05	200	237	10	4824_DN
Drug	Flunitrazepam	CYP3A4 GABRA1 GABRA2 GABRA3	5.96e-05	21	237	4	ctd:D005445
Drug	Adinazolam	GABRA1 GABRA2 GABRA3	6.00e-05	8	237	3	DB00546
Drug	Fludiazepam	GABRA1 GABRA2 GABRA3	6.00e-05	8	237	3	DB01567
Drug	Clotiazepam	GABRA1 GABRA2 GABRA3	6.00e-05	8	237	3	DB01559
Drug	Cinolazepam	GABRA1 GABRA2 GABRA3	6.00e-05	8	237	3	DB01594
Drug	Prazepam	GABRA1 GABRA2 GABRA3	6.00e-05	8	237	3	DB01588
Drug	Murametide	ITGAL ITGAX IL1A	6.00e-05	8	237	3	CID000133276
Drug	Estazolam	GABRA1 GABRA2 GABRA3	6.00e-05	8	237	3	DB01215
Drug	Halazepam	GABRA1 GABRA2 GABRA3	6.00e-05	8	237	3	DB00801
Drug	1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane	GABRA1 GABRA2 GABRA3	6.00e-05	8	237	3	ctd:C091518
Drug	propoxyphene	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2	7.01e-05	67	237	6	CID000010100
Drug	etizolam	CYP2C18 CYP3A4 GABRA1 GABRA2	7.23e-05	22	237	4	CID000003307
Drug	felodipine	CYP3A7 PDE1A PDE3A CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 CACNA1A	7.27e-05	169	237	9	CID000003333
Drug	gefitinib	HDAC9 CYP3A4 PAOX KIDINS220 BRAF FLT4 NRG2 IFI27 CCNB3 MTOR MAPK10	7.96e-05	255	237	11	CID000123631
Drug	zolpidem	CYP3A4 AFF2 GABRA1 GABRA2 GABRA3	8.17e-05	43	237	5	CID000005732
Drug	4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide	CYP2C18 CYP2D6 CYP3A4	8.93e-05	9	237	3	ctd:C545880
Drug	Ethchlorvynol	GABRA1 GABRA2 GABRA3	8.93e-05	9	237	3	DB00189
Drug	Diazepam	GABRA1 GABRA2 GABRA3	8.93e-05	9	237	3	DB00829
Drug	tiotidine	GABRA1 GABRA2 GABRA3	8.93e-05	9	237	3	ctd:C023990
Drug	2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine	CYP11B1 ITGAL CD44	8.93e-05	9	237	3	ctd:C104564
Drug	4-bromophenol	CYP3A7 CYP2C18 CYP2D6 CYP3A4 TAF1 CNR2	8.98e-05	70	237	6	CID000007808
Drug	Sparteinum	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2 NR4A3	9.09e-05	101	237	7	CID000003966
Drug	carteolol	CYP3A7 CYP2C18 CYP2D6 CYP3A4 CYP11B1 CYP11B2	1.05e-04	72	237	6	CID000002583
Drug	cyadox	CYP11B1 CYP11B2	1.08e-04	2	237	2	ctd:C020728
Drug	norlevorphanol	CYP2D6 CYP3A4	1.08e-04	2	237	2	ctd:C054116
Drug	norbuprenorphine	CYP2D6 CYP3A4	1.08e-04	2	237	2	ctd:C043585
Drug	18-hydroxydeoxycorticosterone	CYP11B1 CYP11B2	1.08e-04	2	237	2	ctd:C042509
Drug	Pyrantel	CYP2D6 CYP3A4	1.08e-04	2	237	2	ctd:D011715
Drug	desethylchloroquine	CYP2D6 CYP3A4	1.08e-04	2	237	2	ctd:C007278
Drug	YM 758	CYP2D6 CYP3A4	1.08e-04	2	237	2	ctd:C530155
Drug	N,O-didesmethylvenlafaxine	CYP2D6 CYP3A4	1.08e-04	2	237	2	ctd:C434333
Drug	Secobarbital	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB00418
Drug	Chlordiazepoxide	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB00475
Drug	Metharbital	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB00463
Drug	Pentobarbital	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB00312
Drug	Talbutal	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB00306
Drug	Clobazam	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB00349
Drug	Butalbital	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB00241
Drug	Butabarbital	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB00237
Drug	Bromazepam	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB01558
Drug	Barbituric acid derivative	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB01496
Drug	Barbital	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB01483
Drug	Hexobarbital	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB01355
Drug	Aprobarbital	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB01352
Drug	Amobarbital	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB01351
Drug	Heptabarbital	GABRA1 GABRA2 GABRA3	1.27e-04	10	237	3	DB01354
Disease	Intellectual Disability	HDAC4 MAP1B ZMYM2 HMGCL PCDH12 TRRAP BPTF SLC5A6 TAF1 MED13 CERT1 SHANK3 SETD2 MTOR VPS53 STAG2 GABRA2	1.33e-07	447	235	17	C3714756
Disease	Malignant neoplasm of breast	CYP2D6 HDAC4 CYP3A4 SIX4 EPB41L3 OR1N1 EFEMP1 BRAF FAM83F ARHGAP29 ADGRF4 DNAH9 CNR2 RASAL2 SMARCAL1 DVL3 ELP1 NSMCE2 SETD2 NLRP9 LLGL1 MTOR ROBO1 LRBA L3MBTL3 TNS1	5.32e-07	1074	235	26	C0006142
Disease	tauro-beta-muricholate measurement	CYP3A7 CYP3A4 ZNF394	4.93e-06	5	235	3	EFO_0800213
Disease	glyco-beta-muricholate measurement	CYP3A7 CYP3A4 ZNF394	4.93e-06	5	235	3	EFO_0800569
Disease	androstenediol (3beta,17beta) monosulfate (1) measurement	CYP3A7 CYP3A4 ZNF394	9.80e-06	6	235	3	EFO_0800294
Disease	metabolonic lactone sulfate measurement	CYP3A7 CYP2C18 CYP3A4 ZNF394	1.38e-05	19	235	4	EFO_0800659
Disease	X-24947 measurement	CYP3A7 CYP3A4 ZNF394 UGT2B4	2.56e-05	22	235	4	EFO_0800910
Disease	androstenediol (3beta,17beta) disulfate (1) measurement	CYP3A7 CYP3A4 ZNF394	4.04e-05	9	235	3	EFO_0800278
Disease	5alpha-androstan-3beta,17alpha-diol disulfate measurement	CYP3A7 CYP3A4 ZNF394	5.74e-05	10	235	3	EFO_0800289
Disease	Glucocorticoid-remediable aldosteronism	CYP11B1 CYP11B2	6.32e-05	2	235	2	C1260386
Disease	adrenal cortical adenoma (is_marker_for)	CYP11B1 CYP11B2	6.32e-05	2	235	2	DOID:0050891 (is_marker_for)
Disease	DNA repair protein RAD51 homolog 4 measurement	CYP3A7 CYP3A4 ZNF394	7.85e-05	11	235	3	EFO_0801531
Disease	androstenediol (3beta,17beta) monosulfate (2) measurement	CYP3A7 CYP3A4 ZNF394	7.85e-05	11	235	3	EFO_0800295
Disease	Epileptic encephalopathy	CACNA1A MTOR MAPK10 GABRA1	9.13e-05	30	235	4	C0543888
Disease	Schizophrenia	HDAC9 CYP2D6 HDAC4 CYP3A4 SREBF1 NFASC CSMD2 TRRAP NRXN3 NUFIP2 ADGRF4 CNR2 CLOCK SHANK3 PITPNM1 MTOR ERVK-8 PCM1 GABRA1	9.35e-05	883	235	19	C0036341
Disease	Global developmental delay	TRRAP SLC5A6 TAF1 SZT2 VPS53 STAG2 GABRA2	9.88e-05	133	235	7	C0557874
Disease	5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement	CYP3A7 CYP3A4 ZNF394	1.04e-04	12	235	3	EFO_0800291
Disease	Ovarian Mucinous Adenocarcinoma	TRRAP NRBP1 ALPK1 MTOR	1.04e-04	31	235	4	C1335167
Disease	Large cell carcinoma of lung	TRRAP MTOR STK33 EPHA3	1.18e-04	32	235	4	C0345958
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	CDH23 PDZD7 TMEM132E	1.34e-04	13	235	3	C1846647
Disease	renal sinus adipose tissue measurement	GLT1D1 TIAM1 L3MBTL3	1.34e-04	13	235	3	EFO_0004864
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	CYP3A7 CYP3A4 ZNF394	1.34e-04	13	235	3	EFO_0800293
Disease	5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement	CYP3A7 CYP3A4 ZNF394	1.34e-04	13	235	3	EFO_0800284
Disease	X-21470 measurement	CYP3A7 CYP3A4 ZNF394	1.70e-04	14	235	3	EFO_0800817
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	CYP3A7 CYP3A4 ZNF394	1.70e-04	14	235	3	EFO_0800283
Disease	Ondansetron response	CYP2D6 CYP3A4	1.88e-04	3	235	2	cv:CN417142
Disease	congenital adrenal hyperplasia (implicated_via_orthology)	CYP11B1 CYP11B2	1.88e-04	3	235	2	DOID:0050811 (implicated_via_orthology)
Disease	Developmental delay (disorder)	SLC5A6 SZT2 VPS53 GABRA2	2.11e-04	37	235	4	C0424605
Disease	16a-hydroxy DHEA 3-sulfate measurement	CYP3A7 CYP3A4 ZNF394	2.11e-04	15	235	3	EFO_0800301
Disease	Mental Depression	HDAC9 CYP2D6 HDAC4 CSMD2 CNR2 PCLO CLOCK IL1A GABRA3	2.15e-04	254	235	9	C0011570
Disease	autism spectrum disorder (implicated_via_orthology)	DSCAML1 NRXN3 WDR75 PRICKLE1 SHANK3 LRBA CTNND1	2.26e-04	152	235	7	DOID:0060041 (implicated_via_orthology)
Disease	Tremor, Rubral	CACNA1A ARCN1 GABRA1	2.59e-04	16	235	3	C0750940
Disease	Ataxia, Appendicular	CACNA1A ARCN1 GABRA1	2.59e-04	16	235	3	C0750937
Disease	Ataxia, Motor	CACNA1A ARCN1 GABRA1	2.59e-04	16	235	3	C0278161
Disease	Ataxia, Sensory	CACNA1A ARCN1 GABRA1	2.59e-04	16	235	3	C0240991
Disease	X-21410 measurement	CYP3A7 CYP3A4 ZNF394	2.59e-04	16	235	3	EFO_0800813
Disease	Abnormal coordination	CACNA1A ARCN1 GABRA1	2.59e-04	16	235	3	C0520966
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	UBR5 ARHGAP29 MTOR	2.59e-04	16	235	3	C0334634
Disease	Ataxia, Truncal	CACNA1A ARCN1 GABRA1	2.59e-04	16	235	3	C0427190
Disease	andro steroid monosulfate C19H28O6S (1) measurement	CYP3A7 CYP3A4 ZNF394	2.59e-04	16	235	3	EFO_0800305
Disease	Disorder of eye	PDE6C CDH23 PDZD7 CHM EFEMP1 ALMS1 GPR143 SLC24A1	3.16e-04	212	235	8	C0015397
Disease	5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement	CYP3A7 CYP3A4 ZNF394	3.73e-04	18	235	3	EFO_0800288
Disease	dextro-looped transposition of the great arteries (implicated_via_orthology)	HSPG2 DVL2	3.75e-04	4	235	2	DOID:0060770 (implicated_via_orthology)
Disease	tacrolimus measurement	CYP3A7 CYP3A4	3.75e-04	4	235	2	EFO_0008458
Disease	estrone conjugate measurement	CYP3A7 CYP3A4	3.75e-04	4	235	2	EFO_0007971
Disease	Clozapine response	CYP2D6 CYP3A4	3.75e-04	4	235	2	cv:CN077971
Disease	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	PDE1A CDH23 PCLO	4.40e-04	19	235	3	EFO_0007044, EFO_0020106
Disease	etiocholanolone glucuronide measurement	CYP3A7 CYP3A4 ZNF394	4.40e-04	19	235	3	EFO_0800362
Disease	childhood trauma measurement, smoking behaviour measurement	NRXN3 SVIL RIC1 PAPPA2	4.52e-04	45	235	4	EFO_0005671, EFO_0007979
Disease	Acute Promyelocytic Leukemia	ASXL1 ITGAL ITGAX CD44	4.92e-04	46	235	4	C0023487
Disease	androsterone glucuronide measurement	CYP3A7 CYP3A4 UGT2B4	5.14e-04	20	235	3	EFO_0800317
Disease	chronic granulomatous disease (implicated_via_orthology)	NCF1C NCF1B	6.22e-04	5	235	2	DOID:3265 (implicated_via_orthology)
Disease	X-24020 measurement	PAOX TUBGCP6	6.22e-04	5	235	2	EFO_0022128
Disease	primary hyperaldosteronism (is_implicated_in)	CYP11B1 CYP11B2	6.22e-04	5	235	2	DOID:446 (is_implicated_in)
Disease	initial pursuit acceleration	PCDH12 RTN1 NRXN3 MED13 LMO7	6.67e-04	87	235	5	EFO_0008434
Disease	5alpha-androstan-3beta,17beta-diol disulfate measurement	CYP3A7 CYP3A4 ZNF394	6.87e-04	22	235	3	EFO_0021115
Disease	Conn Syndrome	CYP11B1 CYP11B2	9.28e-04	6	235	2	C1384514
Disease	dehydroisoandrosterone sulfate DHEA-S measurement	CYP3A7 CYP3A4	9.28e-04	6	235	2	EFO_0021119
Disease	Cannabis use	CNR2 GABRA2	9.28e-04	6	235	2	C3160814
Disease	Hyperaldosteronism	CYP11B1 CYP11B2	9.28e-04	6	235	2	C0020428
Disease	neuroimaging measurement	HDAC9 DCHS2 MAP1B SMARCAD1 NRP1 LRRIQ1 WDR75 SYCP1 NAV3 CAMTA1 MRC1 PDPR SZT2 ROBO1 SSH2 L3MBTL3 TNS1 FGD6 EPHA3	9.90e-04	1069	235	19	EFO_0004346
Disease	epiandrosterone sulfate measurement	CYP3A7 CYP3A4 ZNF394	1.01e-03	25	235	3	EFO_0021120
Disease	Ataxia	CACNA1A ARCN1 GABRA1	1.01e-03	25	235	3	C0004134
Disease	response to lithium ion	HDAC9 SLCO4A1 CSMD2 NRXN3	1.04e-03	56	235	4	GO_0010226
Disease	Autistic Disorder	MARK1 TRRAP NRXN3 SHANK3 ROBO1 GABRA1 GABRA2 GABRA3	1.23e-03	261	235	8	C0004352
Disease	Pancreatic Neoplasm	NRP1 EFEMP1 SYCP1 CNR2 CD44	1.25e-03	100	235	5	C0030297
Disease	drug use measurement, quality of life during menstruation measurement	SYCP1 IL1A	1.29e-03	7	235	2	EFO_0007010, EFO_0009366
Disease	protocadherin alpha-7 measurement	CYP11B1 CYP11B2	1.29e-03	7	235	2	EFO_0801973
Disease	Pilomyxoid astrocytoma	BRAF KIAA1549	1.29e-03	7	235	2	C1519086
Disease	X-24574 measurement	CYP3A7 CYP3A4	1.29e-03	7	235	2	EFO_0800897
Disease	Malignant neoplasm of pancreas	NRP1 EFEMP1 SYCP1 CNR2 CD44	1.37e-03	102	235	5	C0346647
Disease	brain measurement, neuroimaging measurement	HDAC9 DCHS2 DSCAML1 NRP1 BPTF LRRIQ1 NAV3 ROBO1 SSH2 TNS1 FGD6 EPHA3	1.64e-03	550	235	12	EFO_0004346, EFO_0004464
Disease	Malignant mesothelioma	HDAC4 EFEMP1 SETD2 IL1A FGD6	1.83e-03	109	235	5	C0345967
Disease	eye morphology measurement	MAP1B CDH23 NAV3 WDR27 CAPRIN2 ARHGAP45 PCM1	1.90e-03	218	235	7	EFO_0007858
Disease	putamen volume	RTN1 DSCAML1 JPH3	1.90e-03	31	235	3	EFO_0006932
Disease	Microcephaly	PCDH12 TRRAP SLC5A6 STAG2	2.03e-03	67	235	4	C0025958
Disease	dehydroepiandrosterone sulphate measurement	CYP3A7 CYP3A4 ZNF394 CAMTA1	2.14e-03	68	235	4	EFO_0007001
Disease	temporal lobe epilepsy (implicated_via_orthology)	PRICKLE1 MTOR	2.19e-03	9	235	2	DOID:3328 (implicated_via_orthology)
Disease	glucose metabolism decline measurement, cingulate cortex measurement	CDH23 VPS53	2.19e-03	9	235	2	EFO_0007738, EFO_0009392
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	CYP2C18 UGT2B4	2.19e-03	9	235	2	EFO_0600040
Disease	protein FAM163B measurement	CYP11B1 CYP11B2	2.19e-03	9	235	2	EFO_0802936
Disease	vital capacity	HDAC9 PDE3A SIX4 EFEMP1 LRRIQ1 BRAF RTL9 SYCP1 MIGA1 PAPPA2 HSPG2 PCLO WDR27 STK31 KCNH3 CAPRIN2 LRBA L3MBTL3 TNS1 EPHA3	2.23e-03	1236	235	20	EFO_0004312
Disease	androsterone sulfate measurement	CYP3A7 CYP3A4 ZNF394	2.28e-03	33	235	3	EFO_0021117
Disease	Depressive disorder	HDAC9 CYP2D6 CSMD2 CNR2 PCLO CLOCK IL1A GABRA3	2.33e-03	289	235	8	C0011581
Disease	alcohol consumption measurement	TOPAZ1 ZBTB37 STOX2 NRXN3 ALMS1 NUFIP2 CAMTA1 CACNA1A NRBP1 PCLO CALCOCO1 ALPK1 GARIN2 MTOR STK33 AKAP11 ASXL2 EPHA3 GABRA2 PHLPP2	2.35e-03	1242	235	20	EFO_0007878
Disease	Carcinoma, Granular Cell	EFEMP1 SYCP1 MTOR ROBO1 HRH4	2.41e-03	116	235	5	C0205644
Disease	Adenocarcinoma, Tubular	EFEMP1 SYCP1 MTOR ROBO1 HRH4	2.41e-03	116	235	5	C0205645
Disease	Adenocarcinoma, Oxyphilic	EFEMP1 SYCP1 MTOR ROBO1 HRH4	2.41e-03	116	235	5	C0205642
Disease	Carcinoma, Cribriform	EFEMP1 SYCP1 MTOR ROBO1 HRH4	2.41e-03	116	235	5	C0205643
Disease	Adenocarcinoma, Basal Cell	EFEMP1 SYCP1 MTOR ROBO1 HRH4	2.41e-03	116	235	5	C0205641
Disease	Adenocarcinoma	EFEMP1 SYCP1 MTOR ROBO1 HRH4	2.41e-03	116	235	5	C0001418
Disease	susceptibility to childhood ear infection measurement	CHM EFEMP1 NUP210 C22orf42 ELP1 MUC22	2.56e-03	171	235	6	EFO_0007904
Disease	4-androsten-3alpha,17alpha-diol monosulfate (3) measurement	CYP3A7 CYP3A4	2.72e-03	10	235	2	EFO_0022090
Disease	androstenedione measurement	CYP11B1 CYP11B2	2.72e-03	10	235	2	EFO_0007972
Disease	Lymphoma, Lymphocytic, Intermediate	ARHGAP29 MTOR	3.31e-03	11	235	2	C0751958
Disease	cell growth regulator with EF hand domain protein 1 measurement	CYP11B1 CYP11B2	3.31e-03	11	235	2	EFO_0801461
Disease	gastric adenocarcinoma (is_implicated_in)	UBR5 CD44	3.31e-03	11	235	2	DOID:3717 (is_implicated_in)
Disease	nucleus accumbens volume change measurement	MUC16 MAPK10	3.31e-03	11	235	2	EFO_0021493
Disease	3-hydroxyanthranilate 3,4-dioxygenase measurement	CYP11B1 CYP11B2	3.31e-03	11	235	2	EFO_0021862
Disease	Malignant Neoplasms	BRAF SETD2 MTOR ARHGAP45 EPHA3	3.67e-03	128	235	5	C0006826

Protein segments in the cluster

Peptide	Gene	Start	Entry
TDVDTGLGTDLSMTT	CACNA1A	2171	O00555
IMSGVFSFVNTLSDS	APH1B	126	Q8WW43
GTDFSVSSSASMDTV	BRAF	106	P15056
GSLSQSATVFMSEVT	CAMTA1	391	Q9Y6Y1
NVATTTVSDDVSMTF	EIF3G	116	O75821
EMLLAGVDTTSFTLS	CYP27C1	346	Q4G0S4
VDTLAVFMASSGTTD	APBB2	11	Q92870
ADNTVTMLGSFSGTT	CSMD2	1856	Q7Z408
ASTVAETMLSSTITG	ADGRG4	591	Q8IZF6
ITMSDGATSTFDLFE	ABHD2	101	P08910
ITSTITTGLMDSSHL	AFF2	1026	P51816
ITDMVKSSETTSGNI	ADGRF4	146	Q8IZF3
GLADQTTGMSTLTST	ALMS1	606	Q8TCU4
MTSASTKVGEIFSAA	BAP18	1	Q8IXM2
GASFAESLATETMTA	AKAP11	1681	Q9UKA4
SVSLEDFMTSGLSES	C22orf42	191	Q6IC83
DFMTSGLSESLSVSL	C22orf42	196	Q6IC83
SSTLMSSELETTSFF	DVL3	176	Q92997
GTLVTSMTVSKEYST	BPTF	1796	Q12830
MDFLINSSSGVVVTT	CDH23	936	Q9H251
NTVCDGSVFTSDLMS	CCDC14	896	Q49A88
VDIIEQMSSSSGSSS	EAF1	181	Q96JC9
STLMTSELESTSLGD	DVL2	196	O14641
AETFTLSSNIIMDTS	ATG2A	1136	Q2TAZ0
SFGTSTAMAALELTN	ATG2B	1931	Q96BY7
ASLSLQMFTDSSTVE	ASXL1	1486	Q8IXJ9
SSNVGDVMSFSVTVT	ASXL2	1351	Q76L83
STSLGILADIFVSMS	ALPK1	236	Q96QP1
SITEKSSIATMTSVG	CCNB3	1066	Q8WWL7
GSVTMTFTASVGSLL	CNR2	111	P34972
IAMTSETASSTIDGL	CHM	341	P24386
LNATSGMVTSFELSD	RBM33	91	Q96EV2
GLSDIAMDTTVTHAT	HSPG2	706	P98160
TASLLSSVTQGMESA	RABEP1	486	Q15276
IGSATDLTESSSMVD	RIC1	1211	Q4ADV7
TTSSSSFELEMAQEG	ITGAX	341	P20702
TGDTSTSSLLSEMSS	PCDH18	996	Q9HCL0
TGTRLASTFVSEMSS	PCDH12	1101	Q9NPG4
AEVDTSSLSGDNTLM	KCNH3	711	Q9ULD8
SETSVGISAEVDMSS	KIAA1549	501	Q9HCM3
GISAEVDMSSVTTTQ	KIAA1549	506	Q9HCM3
MSIDSATSADTTLDT	LLGL1	1011	Q15334
MTESASSTSGQEFDV	L3MBTL3	1	Q96JM7
SSMSSIDLVSASDDV	CERT1	376	Q9Y5P4
ASGSMIGTSTIEVIA	NUP210	1341	Q8TEM1
QGSMSIAASLVSEDT	RELCH	1176	Q9P260
QSASTALMGESAEVL	HCFC1	1521	P51610
ALMGESAEVLSASQT	HCFC1	1526	P51610
SSATLMSTALGSTEN	MUC16	1791	Q8WXI7
TSFLASSTELDSMST	MUC16	3616	Q8WXI7
VTSHIMGDITSSTSV	MUC16	4276	Q8WXI7
MGDITSSTSVFGSSE	MUC16	4281	Q8WXI7
SLIMTESSGVTITTQ	MUC16	4376	Q8WXI7
TSSSEGTSLATEMST	MUC16	8126	Q8WXI7
GTSLATEMSTVLSGV	MUC16	8131	Q8WXI7
IMTESAESAITIETG	MUC16	8486	Q8WXI7
EMVTSQITSSGAATS	MUC16	11741	Q8WXI7
TDDFTTSMGIAEGTA	MUC6	541	Q6W4X9
GCMDQSVSLSISETS	IL1A	46	P01583
MEASALTSSAVTSVA	IFI27	1	P40305
SSVGGETSLAEMIAT	KIDINS220	606	Q9ULH0
TSTSTEEEAIQGMLS	KDM7A	726	Q6ZMT4
EEAETVTAMASLSVG	HDAC4	1051	P56524
STVSEFLMGEVDSST	ARHGAP45	216	Q92619
TSSSGTMSSTEELVD	ARHGAP45	646	Q92619
MEGVASVSTASVATS	MAP1B	1546	P46821
SSSTLIMGTLEEVTD	MAGEA8	41	P43361
ISSMSTDQTLASDTD	MAPK10	436	P53779
ATATTSTSGMVEASQ	LRIF1	211	Q5T3J3
SVGSDEATLSMTVEN	SLC24A1	96	O60721
MAVSSSVGSNIFDIT	SLC24A1	1001	O60721
SALTAAVTMATEEGV	GMEB1	231	Q9Y692
DTTTASITGSETTMA	MUC22	36	E2RYF6
AGSEKTMASSIISET	MUC22	161	E2RYF6
TTAASTTGSEMTTVF	MUC22	416	E2RYF6
TTGSEMTTVFTAGSE	MUC22	421	E2RYF6
TTASIMGSETSTDST	MUC22	606	E2RYF6
TDSETTTTCTEGSEM	MUC22	661	E2RYF6
EGSEMTAVSTTVFET	MUC22	671	E2RYF6
TGLETTTTSTEGSEM	MUC22	801	E2RYF6
EGSEMTTVSTTGAET	MUC22	811	E2RYF6
TDSETTMVSTTGSER	MUC22	901	E2RYF6
MASTIGSETTKVSTA	MUC22	1036	E2RYF6
FMASSIFSLTDQGTT	IMPG1	451	Q17R60
IFSLTDQGTTDTMAT	IMPG1	456	Q17R60
MSGDLSSNVTVSVTS	KRT2	491	P35908
GVTTVLTMTTLSISA	GABRA2	286	P47869
MDVITSTSFGVNIDS	CYP3A4	181	P08684
LLSMEVSDTSDSEQG	MFSD6L	556	Q8IWD5
EISTGTQSTFSTMGT	PCLO	3731	Q9Y6V0
VMDDSVVAETAGSLS	PCM1	316	Q15154
MSSFTKFEITSTGDQ	PDPR	526	Q8NCN5
MGSSATEIEELENTT	PDE1A	1	P54750
VNGLSLESTTMGSAV	PDZD7	136	Q9H5P4
LESTTMGSAVKVLTS	PDZD7	141	Q9H5P4
SQSSGTSITVDIAVM	PDE3A	336	Q14432
SSMSFSELTQVEESA	PDE6C	46	P51160
MEEVHGSSLSLVSST	NAV3	1541	Q8IVL0
SESLTSDSQSGIMLS	NRG2	526	O14511
SDSQSGIMLSSVGTS	NRG2	531	O14511
TSSAAASVLTVMLIT	GPR119	86	Q8TDV5
SGMDTASSVALDLVE	NSMCE2	36	Q96MF7
QTAMESELGESSATI	DEPDC1	546	Q5TB30
RSTTTSDMIAEVGAA	NAXD	326	Q8IW45
STGSMSVVSAALVAE	RASAL2	896	Q9UJF2
SSNSFITTGKDSMTV	LRBA	1061	P50851
ITTGKDSMTVSEVTA	LRBA	1066	P50851
ATLSSTSGLDLMSES	LMO7	1006	Q8WWI1
SMILEEVGQFTSSSL	LMNTD1	131	Q8N9Z9
GVTTVLTMTTLSISA	GABRA3	311	P34903
GVTTVLTMTTLSISA	GABRA1	286	P14867
VSDASISLGESVSDM	TUBGCP6	1191	Q96RT7
FSETSSVVSGSEMSG	ELP1	1166	O95163
STGSLQEMLSDGTDT	KIAA1549L	556	Q6ZVL6
GAMLASQETSSSATS	EXOC7	521	Q9UPT5
TDLDLFSMTNGSALS	LRRIQ1	1681	Q96JM4
TSGSEMALSTGDVVE	NCF1B	171	A6NI72
TSGSEMALSTGDVVE	NCF1C	146	A8MVU1
MSEGESQTVLSSGSD	NRBP1	1	Q9UHY1
TFMLDESSGLLTTTC	DCHS2	1666	Q6V1P9
GMVSGLISDSQITSS	NRP1	436	O14786
SMDSLALSNITGASV	PRICKLE1	536	Q96MT3
SRDNEGISSTVITFM	NFASC	1186	O94856
SAMAATTTTAIFTTL	PAPPA2	166	Q9BXP8
TTVGATFLMESAQDL	PCDHB14	146	Q9Y5E9
ASGQLSTDITTSEMG	ARHGAP29	16	Q52LW3
TVSASNLGTADMATF	COG6	486	Q9Y2V7
VASIVDVSMDSGSLV	FAM189B	316	P81408
TTTMEDILIFATGCS	G2E3	626	Q7L622
NSTETQTMSSGFETL	ATMIN	761	O43313
DVIGASDTMETSQAL	EPB41L5	466	Q9HCM4
EVSMLATTGLSEATT	IGSF10	1591	Q6WRI0
TLSATMSSQTLGKEE	CD101	146	Q93033
ETIVSMDFVASTSVG	BPIFC	376	Q8NFQ6
MTTSLDTVETFGTTS	CCR3	1	P51677
ATTLMSTSATATETA	CD44	221	P16070
VNSSVSEGMSAAILE	GLT1D1	246	Q96MS3
IGALNTSSETVMESN	DCST1	521	Q5T197
ISDSSSDQMTTGTNE	DSCAML1	1836	Q8TD84
DLFSAGMVTTSTTLA	CYP2D6	301	P10635
VSNSDFVTMTTFLSD	COL6A5	1016	A8TX70
TASRSSIITATMEFS	COL6A5	1876	A8TX70
EALSMLSEGSDASTI	GPR143	366	P51810
TMLTNETGFEISSSD	ILF2	156	Q12905
SGDSGSLATSISQMV	ILKAP	56	Q9H0C8
LSASVGSSAVMSTAI	GPAT2	451	Q6NUI2
ANSMELTAGSVDTTV	CYP11B1	306	P15538
SDVVEGMELNSSITS	DLGAP5	746	Q15398
DSFSISGESSQVVMI	EPHA3	531	P29320
SGESSQVVMIAISAA	EPHA3	536	P29320
VTTDQASSGSETEFM	CAPRIN2	696	Q6IMN6
TEMSVSSISSAGSSV	MARK1	526	Q9P0L2
DLLVAADSITNTMSS	DTNA	616	Q9Y4J8
VTDMFGAGTETTSTT	CYP2C18	291	P33260
ANSMELTAGSVDTTA	CYP11B2	306	P19099
EQVAMTLASAISEGT	E4F1	721	Q66K89
TMASISESASLFEVN	DNAH9	1271	Q9NYC9
MDVITSTSFGVSIDS	CYP3A7	181	P24462
KRMFEVTESSVSSSS	HDAC9	256	Q9UKV0
EASESVSSTNFSGEM	RNF103	91	O00237
SEMSGATTSLATVAL	SLC12A6	61	Q9UHW9
MASGFTVGTLSETST	CALCOCO1	631	Q9P1Z2
VSGGSTAAMITETII	ARCN1	191	P48444
MSVVSVETSDDGTTR	CTNND1	121	O60716
GVLMSAQTITSETTS	EPB41L3	1001	Q9Y2J2
SQTTSSEISSVMVGE	PPP4R2	261	Q9NY27
SEISSVMVGETEASS	PPP4R2	266	Q9NY27
SNSSKTGEILSESSM	PPP4R2	386	Q9NY27
ASSGASVSLQLVAEM	PAOX	116	Q6QHF9
VSTGMVAASFSQEVS	SLC16A6	101	O15403
LANLSFVDMGLTSST	OR1N1	61	Q8NGS0
DDMSISGSTGVIQSS	MINAR1	526	Q9UPX6
MASTSNVTELIFTGL	OR4B1	1	Q8NGF8
STAMDTLSSLVFQLG	MTOR	1171	P42345
AISSSATLDSTTMSV	MUC17	3731	Q685J3
MGSSLVSIESAAESS	MRC1	1266	P22897
GAMSEETVSESQFSL	MIGA1	31	Q8NAN2
TKLTMDLGSTEITAT	NR4A3	36	Q92570
DSTLTVLGMSAVISS	RNF139	286	Q8WU17
EMLTVSSIGTFRTSS	EFEMP1	466	Q12805
SGITNSTDITGSMDV	GARIN2	191	Q8N9W8
STDITGSMDVTDVTT	GARIN2	196	Q8N9W8
GSMDVTDVTTFTAIL	GARIN2	201	Q8N9W8
TIASKMGSFSQSDSV	HRH4	271	Q9H3N8
SSLLMSGTDSEAISS	RTL9	256	Q8NET4
SGTDSEAISSLIMSA	RTL9	261	Q8NET4
ETMASGATSTLQTSV	RTL9	981	Q8NET4
ETASTGVAGVSSAMD	RTN1	76	Q16799
SILSEFTALVTSMAG	SZT2	2556	Q5T011
TTAGTEEAMNTTSLL	HHLA1	356	C9JL84
LTDVFGSVMLTGSAS	MEIOC	46	A2RUB1
EMSQTSSIGSAESLI	STK33	41	Q9BYT3
ESGKMNAESVITSSS	TMEM71	176	Q6P5X7
ASGLNTSTGTIDDMS	PRUNE2	2306	Q8WUY3
IESTSTMDGAIAAAL	SMARCAD1	181	Q9H4L7
STVSEKGTSALMTVE	SVIL	1821	O95425
SVAVNSIMSILTGST	TOP6BL	396	Q8N6T0
FHTTSSEGTDQVVTM	TMEM132E	601	Q6IEE7
GDSMTETVAENIVTS	SYNM	631	O15061
TSFGSSENITMTSLS	SYNRG	931	Q9UMZ2
LVAASLSINATGSTM	TDRD9	1196	Q8NDG6
TISSAFNSLATVTME	SLC5A6	366	Q9Y289
TAATITAAAIMSDTD	TAF1	11	P21675
ASEVIRESSSTTGMV	NRXN3	551	Q9HDB5
DMLSEAGLSVIETTS	HMGCL	61	P35914
VLSITAANMGLTFSS	SMARCAL1	781	Q9NZC9
AGLSETNFSEMTEST	SMARCAL1	856	Q9NZC9
GSMLFSASTDKTVAV	SNRNP40	121	Q96DI7
IEMVETGILSSTAFS	SLC9A4	556	Q6AI14
SIADEGETGMFSLST	FTSJ3	411	Q8IY81
VSNGISMTDILGSTS	SIX4	401	Q9UIU6
TMTVFQGDATASTAL	SIGLEC8	251	Q9NYZ4
MVTSITGLSTSAIAT	SLC12A1	221	Q13621
STFLSLMTSTASEAA	DRG2	76	P55039
GTSSVTVLSHEEDAM	MED13	731	Q9UHV7
LASAASSTMTVTSGV	MED13	1506	Q9UHV7
DLTSFNMELSSSGIS	ITGAL	341	P20701
ASTSTSDGMLTLDLI	PLEKHO1	176	Q53GL0
MASSVSTETSEVEFL	FAM83F	456	Q8NEG4
DIMSAQASSGSTSVL	RRP12	196	Q5JTH9
AGATEATLITGMSTF	SLCO4A1	391	Q96BD0
SFSISSSMATTTGVD	SREBF1	856	P36956
SIQMSEISVTSFTGC	BRS3	376	P32247
MTDGSIIYVSESVTS	CLOCK	126	O15516
FGISTEEIVSMLETS	NLRP9	496	Q7RTR0
SATESVSFSGIVQMD	STK31	11	Q9BXU1
SIDGSFTASVSIMGS	PITPNM1	1026	O00562
ASDGSTETLAMVVVE	PLEKHG5	751	O94827
SSVESLSQDVMRSFT	VPS52	651	Q8N1B4
SQGMVTFEDTAVSLT	ZNF394	151	Q53GI3
SSAEEVTAMVIDTTG	ZBTB37	266	Q5TC79
ALETISISSHSDMAT	TTC39B	86	Q5VTQ0
MSEAGEATTTTTTTL	YBX3	1	P16989
ETASTRFEMFSLSGT	VNN1	416	O95497
DMATETDASLSTLLT	TDRKH	511	Q9Y2W6
VSETSGLMLTASEDG	TEP1	2246	Q99973
LEMSTTNSESLEEAG	TIAM1	391	Q13009
ISSGTDSVLQDMSLT	NUFIP2	446	Q7Z417
IASEFSSEMSTSEVS	PHLPP2	1076	Q6ZVD8
SSEMSTSEVSSEVGS	PHLPP2	1081	Q6ZVD8
SIVLGMDFSSNDSST	SSH2	121	Q76I76
TMVHLEGFTEQSSTT	SSH2	1136	Q76I76
ISTVSSMSTLSSESG	SHANK3	1376	Q9BYB0
SMSTLSSESGELTDT	SHANK3	1381	Q9BYB0
LTSIFNSSSTLFTMD	SLC5A10	381	A0PJK1
VFSLGSMVSNTSEER	UGT2B4	306	P06133
EGMQLSLTEESSSSD	STAG2	1086	Q8N3U4
VMDLAFSVTGTSLLS	WDR75	251	Q8IWA0
VFEDSAAVTSMQISS	SEMA3B	481	Q13214
NSDSSETTDLLSMVS	SYCP1	891	Q15431
SMDSSSITVDSGFNS	STOX2	846	Q9P2F5
VLSGDTMNSTFSEIF	TKTL2	341	Q9H0I9
SQSSEEGSFSQVSTM	FLT4	1191	P35916
MGTLSSLDGVTNTSE	TNS1	516	Q9HBL0
SDSTTVDGSSMSLAV	FGD6	426	Q6ZV73
ITSDSLLTASMASES	WDR44	281	Q5JSH3
ALSLVDMGSSDGETT	UPK3A	231	O75631
EMSQTVSTGESIILS	SIRPD	36	Q9H106
DSVSLMSGTLESLAD	TBC1D10B	271	Q4KMP7
SMTSSVLGSSVDQLS	TECPR2	506	O15040
MVSAGVLNSSEETAT	ERVK-8	86	P61575
ASSVGDLESSVTGSM	ROBO1	1356	Q9Y6N7
DMSLFATEQLSTGAS	SYNGR3	176	O43761
NLTGEMDTFSTVISS	VPS53	586	Q5VIR6
TDAVLMTSDDSVTGS	SETD2	691	Q9BYW2
MDTSSVGGLELTDQT	ZMYM2	1	Q9UBW7
ESSSLGMSSSVAEFM	TOPAZ1	1511	Q8N9V7
MTEITAEGNASTTTT	TRDN	1	Q13061
QSSLNMDEVSSVSVG	ZXDA	686	P98168
SGMASEISSELSTSE	PHLPP1	1471	O60346
LSTSEMSSEVGSTAS	PHLPP1	1481	O60346
GLSFSMSSAIASVTV	TMEM42	91	Q69YG0
LSTTGAVDMTSLSAV	WDR27	651	A2RRH5
SLTASFMSAVTVLGT	SLC5A12	56	Q1EHB4
GLSFTTTDLSLVEMT	TCFL5	36	Q9UL49
SGSTEATSGTSELVM	TRRAP	2311	Q9Y4A5
TGASELTLSDTVLSM	WDR81	1176	Q562E7
SSGDQEMTATLLTAG	ZKSCAN8	201	Q15776
STSIDAMQGSEELFS	UBR5	1501	O95071
SAAEMLSEQTAALGT	ZNF641	11	Q96N77
SEAGMSTVSSTASDI	JPH3	246	Q8WXH2
ASMTSLGVGEESTTS	MUC12	1261	Q9UKN1
ASMTSLGVGEESTTS	MUC12	3901	Q9UKN1